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Ιθάκη - Κ.Π. Καβάφης
Σα βγεις στον πηγαιμό για την Ιθάκη,
να εύχεσαι νάναι μακρύς ο δρόμος,
γεμάτος περιπέτειες, γεμάτος γνώσεις.
Τους Λαιστρυγόνας και τους Κύκλωπας,
τον θυμωμένο Ποσειδώνα μη φοβάσαι,
τέτοια στον δρόμο σου ποτέ σου δεν θα βρεις,
αν μέν’ η σκέψις σου υψηλή, αν εκλεκτή
συγκίνησις το πνεύμα και το σώμα σου αγγίζει.
Τους Λαιστρυγόνας και τους Κύκλωπας,
τον άγριο Ποσειδώνα δεν θα συναντήσεις,
αν δεν τους κουβανείς μες στην ψυχή σου,
αν η ψυχή σου δεν τους στήνει εμπρός σου.
Να εύχεσαι νάναι μακρύς ο δρόμος.
Πολλά τα καλοκαιρινά πρωιά να είναι
που με τι ευχαρίστησι, με τι χαρά
θα μπαίνεις σε λιμένας πρωτοειδωμένους·
να σταματήσεις σ’ εμπορεία Φοινικικά,
και τες καλές πραγμάτειες ν’ αποκτήσεις,
σεντέφια και κοράλλια, κεχριμπάρια κ’ 
έβενους,
και ηδονικά μυρωδικά κάθε λογής,
όσο μπορείς πιο άφθονα ηδονικά μυρωδικά·
σε πόλεις Aιγυπτιακές πολλές να πας,
να μάθεις και να μάθεις απ’ τους 
σπουδασμένους.
Πάντα στον νου σου νάχεις την Ιθάκη.
Το φθάσιμον εκεί είν’ ο προορισμός σου.
Aλλά μη βιάζεις το ταξείδι διόλου.
Καλλίτερα χρόνια πολλά να διαρκέσει·
και γέρος πια ν’ αράξεις στο νησί,
πλούσιος με όσα κέρδισες στον δρόμο,
μη προσδοκώντας πλούτη να σε δώσει η Ιθάκη.
Η Ιθάκη σ’ έδωσε τ’ ωραίο ταξείδι.
Χωρίς αυτήν δεν θάβγαινες στον δρόμο.
Άλλα δεν έχει να σε δώσει πια.
Κι αν πτωχική την βρεις, η Ιθάκη δεν σε γέλασε.
Έτσι σοφός που έγινες, με τόση πείρα,
ήδη θα το κατάλαβες η Ιθάκες τι σημαίνουν.
Ithaca -  Constantine P. Cavafy
    When you set sail for Ithaca,
    wish for the road to be long,
    full of adventures, full of knowledge.
    The Lestrygonians and the Cyclopes,
    an angry Poseidon — do not fear.
    You will never find such on your path,
    if your thoughts remain lofty, and your spirit
    and body are touched by a fine emotion.
    The Lestrygonians and the Cyclopes,
    a savage Poseidon you will not encounter,
    if you do not carry them within your spirit,
    if your spirit does not place them before you.
    Wish for the road to be long.
    Many the summer mornings to be when
    with what pleasure, what joy
    you will enter ports seen for the first time.
    Stop at Phoenician markets,
    and purchase the fine goods,
    nacre and coral, amber and ebony,
    and exquisite perfumes of all sorts,
    the most delicate fragances you can find.
    To many Egyptian cities you must go,
    to learn and learn from the cultivated.
    Always keep Ithaca in your mind.
    To arrive there is your final destination.
    But do not hurry the voyage at all.
    It is better for it to last many years,
    and when old to rest in the island,
    rich with all you have gained on the way,
    not expecting Ithaca to offer you wealth.
    Ithaca has given you the beautiful journey.
    Without her you would not have set out on 
the road.
    Nothing more does she have to give you.
    And if you find her poor, Ithaca has not de-
ceived you.
    Wise as you have become, with so much 
experience,
    you must already have understood what 
Ithacas mean. 
(Poems 1897-1933)
... because that poem perfectly sums up the PhD process!
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Chapter 1
General Introduction
Part of this chapter has been published in: Biochim Biophys Acta. 2012 Oct 12. 
doi:pii: S0304-4165(12)00284-X. 10.1016/j.bbagen.2012.10.004. [Epub ahead of 
print] 
Review by  Kaimakis P, Crisan M, Dzierzak E
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1. General Introduction
1.1 Hematopoiesis and Hematopoietic stem cells (HSCs)
 Hematopoiesis is a word originating from the two greek words αἷμα (hai-
ma) which means blood and the verb ποιεῖν (poien) which means to make/create. 
Hematopoiesis describes the process by which the organism creates and replen-
ishes all the blood cell types that are required for the physiologic functions of the 
organism. The importance of the blood tissue can be highlighted by the many and 
discrete functions that it performs. These are accomplished through several dif-
ferent cell types forming the blood tissue (erythrocytes, platelets, macrophages, 
neutrophils, eosinophils, basophils, B-cells, T-cells, NK-cells). For example, the red 
blood cells or erythrocytes found in the circulating blood are mainly involved in 
the transport of O2 and CO2. Lymphocytes which are white blood cells are part of 
the immune system and actively participate in the defense of the organism against 
pathogens. In the adult organism hematopoietic cells are found not only in the 
blood but also in hematopoietic tissues such as the bone marrow, spleen, lymph 
nodes and thymus. Importantly, all mature hematopoietic cell types found in the 
blood tissues originate from rare hematopoietic stem cells (HSCs). These founder 
cells are quiescent, long-lived and are at the base of a well-studied cell differentia-
tion hierarchy. HSCs robustly produce all the billions of mature blood cells that are 
required daily and throughout the entire life of the organism. HSCs are clinically 
relevant cells that have been used for over 50 years in transplantation and cell re-
placement therapies for leukemia and monogenic blood-related diseases.
 The generation, growth and maintenance of HSCs are tightly controlled 
– massively reduced number of HSCs leads to anemia whereas unlimited growth 
could possibly result in leukemia. Hence, a variety of molecular mechanisms par-
ticipates and controls HSC. These include extracellular signals that act in co-opera-
tion with cell surface receptors and intracellular signaling pathways, transcriptional 
regulation through pivotal transcription factors and transcription factor complexes 
and chromatin modifications that stabilize the genetic program of hematopoiesis. 
The harmonic cooperation of these mechanisms at the different developmental and 
adult stages of life, influence HSCs and allow for homeostasis of the blood tissue 
and rapid response following hematologic insult. Extensive investigations are being 
performed in this research field to provide insight and understanding into the pre-
cise events that control first the process of HSC generation and subsequently HSC 
expansion and maintenance.
 In this Introduction we focus on the regulation of HSC development in the 
mouse embryo. By performing experiments exploring regulation of the HSC genetic 
program, we attempt to understand how the Gata2 transcription factor, a major 
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regulator of hematopoiesis, affects the fate of the cells that will give rise to HSCs 
and the fate of the HSCs themselves, as they differentiate to all different blood cell 
types.
1.2 Hematopoiesis in the mouse embryo
 In the adult mouse the cohort of several hundred HSCs are located in the 
bone marrow (BM) niche in two anatomical locations, the endosteal niche (in prox-
imity to the osteoblasts of the bones) ((Ellis, Grassinger et al. 2011)), and the vas-
cular niche (in proximity to the vessels) ((Kiel and Morrison 2006; Sugiyama, Kohara 
et al. 2006)). Interactions with these niches allow for the HSCs to be maintained in 
a quiescent state until needed. At any point in time only a few of these HSCs are 
actively cycling. During cell division an HSC will produce a daughter cell that dif-
ferentiates and produces progenitor cells at branchpoints along the hematopoietic 
hierarchy that will yield to specific mature blood cell types. Importantly, the other 
daughter cell retains HSC properties. The defining characteristic of the HSC is its 
self-renewal ability. 
 HSCs in the adult organism are not generated in bone marrow. They are 
generated much earlier during a short period of embryonic developmental time - at 
embryonic day (E) 10.5 to 12.5 in the mouse embryo and at 4-8 weeks gestation of 
the human embryo (Tavian, Robin et al. 2001; Tavian and Peault 2005). After their 
production, HSCs migrate and colonize several different hematopoietic sites dur-
ing embryonic and fetal stages of development before reaching and colonizing the 
bone marrow (BM) niche. Much research is focused on determining what is the first 
site where the HSCs appear in the embryo, what tissues/cells generate these HSCs, 
at what timepoints they are made and what is the genetic program that directs their 
generation.
 Hematopoiesis in the mouse embryo happens in three de novo waves of 
generation (reviewed by (Dzierzak and Speck 2008)) with each one being charac-
terized by the production of different types of mature hematopoietic cells, hema-
topoietic progenitors and/or HSCs (Palis, Robertson et al. 1999). The initial two 
hematopoietic waves of generation provide the embryo with the reservoir of he-
matopoietic cells that can temporally and rapidly produce mature hematopoietic 
cells until the generation of HSCs in the third wave, that result in the establishment 
of the long-lived adult hematopoietic system. Several anatomical sites participate in 
hematopoietic cell generation in the mouse embryo. These are the yolk sac (YS), the 
aorta-gonads mesonephros (AGM) region, the vitelline and umbilical arteries (VA, 
UA), the placenta (PL) and the fetal liver (FL) (Figure 1A).
 The first wave of blood generation produces short-lived primitive erythro-
cytes that are necessary to carry oxygen through the rapidly growing conceptus 
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and also primitive macrophages and megakaryocytes. Primitive erythrocytes are 
generated from aggregates of mesodermal precursors or “hemangioblasts”, in the 
yolk sac blood islands. Described over 100 years ago, the overlapping ontogenic 
appearance of both erythroid and endothelial cells indicates a common mesoder-
mal precursor with at least bi-lineage potential (Murray, Kilham et al. 1946)-(Sabin 
1920). This is further supported by the overlap in genetic programs for the two 
lineages (i.e. expression of Flk-1 (KDR), Scl (Tal1) and CD34) and the lack of both 
lineages in embryos deficient for some of these genes (Shalaby, Rossant et al. 1995; 
Tavian, Hallais et al. 1999; Park, Ma et al. 2005). Hemangioblasts in vivo can first be 
detected not in the yolk sac but in the posterior primitive streak (Huber, Kouskoff 
et al. 2004). As they migrate to the yolk sac they begin their commitment to endo-
thelial and hematopoietic progenitors, with several of these cells contributing to 
the formation of each blood island (Ueno and Weissman 2006). The first wave of 
primitive hematopoietic cell generation begins at E7.5 in the mouse conceptus and 
is highly conserved across vertebrate species, including man (at 16-20 days of gesta-
tion) (Tavian and Peault 2005).
 In the mouse embryo the second wave of hematopoietic cell generation 
begins at E8/8.5, and overlaps with the first wave (Palis, Robertson et al. 1999; 
Medvinsky, Rybtsov et al. 2011). Definitive hematopoietic progenitors are de novo 
generated and some clusters of hematopoietic cells begin to appear in the major 
vasculature at E9.5. These hematopoietic progenitors are functionally more com-
plex than primitive progenitors – they have multilineage potential (producing ery-
throid, myeloid and/or lymphoid cells), but they are not long-lived or self-renewing 
HSCs. De novo definitive progenitor generation occurs in the yolk sac, chorio-al-
lantoic/placenta and the intraembryonic region around the aorta, as revealed by 
mouse embryo explant cultures and the Ncx1-/- mouse model (embryos lack circu-
lation due to no heartbeat (Lux, Yoshimoto et al. 2008; Rhodes, Gekas et al. 2008) 
(reviewed in (Medvinsky, Rybtsov et al. 2011)). Thus, “definitive hematopoietic pro-
genitors” constitute the second wave of hematopoietic specification.
 The third wave of hematopoietic cell specification provides for the genera-
tion of adult type HSCs. Grafting studies in avian embryos provided unequivocal 
proof that the adult blood system is not derived from the yolk sac, but instead from 
an intraembryonic source of cells localizing to the dorsal aorta (reviewed in (Dzier-
zak and Speck 2008; Medvinsky, Rybtsov et al. 2011)). Clusters of hematopoietic 
cells consistently found on the ventral wall of the dorsal aorta and major arteries 
of the chick embryo, led to the proposition that HSCs of the adult hematopoietic 
system arise from vascular endothelial cells (Figure 1B). Work in the mouse em-
bryo showed that the first adult-type HSCs are generated in the intrabody AGM re-
gion (Figure 1A and B). These transplantable HSCs (as potent as adult bone marrow 
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HSCs) are generated beginning at E10.5 (Medvinsky and Dzierzak 1996) and are 
thought to be contained within the vascular clusters within the aorta and vitelline 
and umbilical arteries (North, Gu et al. 1999; de Bruijn, Speck et al. 2000; de Bruijn, 
Ma et al. 2002). The real-time generation of hematopoietic cells from “hemogenic 
endothelial cells” lining the aorta (Figure 1C) has been demonstrated by vital confo-
cal imaging in the mouse and zebrafish embryo (Bertrand, Chi et al. 2010; Boisset, 
van Cappellen et al. 2010; Kissa and Herbomel 2010). It is this third wave of he-
matopoietic cell generation that generates the long-lived self-renewing HSCs that 
migrate, colonize and reside in the bone marrow throughout adult life.
Hemogenic endothelium as a source of definitive hematopoietic progenitors and 
HSCs.
 The generation of definitive hematopoietic progenitors (wave 2) and HSCs 
(wave 3) parallels the appearance of vascular hematopoietic clusters in the aor-
ta, vitelline and umbilical arteries (Figure 1C). Histologic/immunostained sections 
through the midgestation embryo AGM region show that “hemogenic”  endothelial 
cells express some hematopoietic markers, and some hematopoietic cluster cells 
express endothelial markers (Yokomizo, Yamada-Inagawa et al. 2012). Cluster num-
bers peak at E10.5, when HSCs first appear. However, not all hematopoietic cells 
in the clusters are HSCs and not all clusters contain HSCs. There are many more 
cluster cells in the aorta than there are HSCs between E9 and E11. Genetic stud-
ies using Cre-Lox recombination methods for deletion of pivotal intrinsic regula-
tory molecules (such as the Runx1 transcription factor) show that HSC generation 
occurs only during a short window of developmental time (Zovein, Hofmann et al. 
2008; Chen, Yokomizo et al. 2009). It is unclear as yet whether all HSCs/cluster cells 
emerge from hemogenic endothelium, whether larger clusters form by proliferation 
of the emerging cell or through the recruitment of circulating cells. Recently, it was 
suggested that already hematopoietic committed cells (perhaps coming from the 
yolk sac, circulation (Yoder, Hiatt et al. 1997) or other areas (Rybtsov, Sobiesiak et 
al. 2011) could mature to HSCs as they integrate into the appropriate microenviron-
ment (Rybtsov, Sobiesiak et al. 2011).
1.3 Molecular programming of HSC generation is distinct from programming of 
transient waves of hematopoietic cell generation.
 The generation of HSCs in the embryo is special as compared to the earlier 
two waves of blood generation. Each wave produces differentiated hematopoietic 
cells that circulate and move through the embryo to perform specific functions that 
are not so different from the differentiated hematopoietic cells arising from adult 
bone marrow HSCs. However, it is only the third wave that generates HSCs. The 
unique production of HSCs has raised the following questions: Is it the vascular mi-
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croenvironment or the intrinsic program of the hemogenic endothelial cells as they 
take on hematopoietic fate that directs the differences in hematopoietic cell/HSC 
potency, or is it a combination of both regulatory mechanisms? It is possible that 
extrinsic signals (growth factors and morphogens) produced by the microenviron-
ment/niche and delivered to the HSCs or their cellular precursors initiate an intrin-
sic molecular program guiding hematopoietic fate by the activation or expression 
of pivotal transcription factors (Figure 2). Here we will describe some of the well 
known examples of intrinsic and extrinsic regulators of hematopoietic cell fate.
Figure 1
Hematopoietic stem cell develop-
ment in the mouse embryo. A) Depic-
tion of a mouse embryo at day 10.5 
at the time when the first hematopoi-
etic stem cells are generated in the 
aorta. Sites harboring (and/or gener-
ating) hematopoietic cells are shown: 
the extraembryonic yolk sac and pla-
centa, the intraembryonic aorta and 
liver, and the umbilical and vitelline 
vessels that respectively connect the 
placenta and yolk sac to the aorta. 
The dotted line through the trunk of 
the embryo indicates the transverse 
section shown in panel B. B) Depic-
tion of a transverse section through 
an E10.5 mouse embryo with the 
AGM (aorta-gonad-mesonephros/ 
aorta and urogenital ridges) region in 
the red rectangle. The AGM is flanked 
on the dorsal side by the neural tube 
and the somites, and on the ventral 
side by the gut and peritoneum. A 
hematopoietic cluster is indicated on 
the ventral wall of the dorsal aorta. 
Hematopoietic stem cells are local-
ized in the clusters. C) A close up of 
the ventral wall of the aorta showing 
cluster formation. A hemogenic en-
dothelial cell is undergoing the transi-
tion from endothelial cell to a hema-
topoietic cell.
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Figure 2
De novo generation of hematopoietic cells begins shortly after mesoderm formation 
and continues through mouse midgestation. Extrinsic factors that include morpho-
gens such as FGF, Hh and BMPs produced in surrounding microenvironment affect 
mesodermal cells in hematopoietic fate choice and differentiation. These signaling 
pathways, as well as the Notch and VEGF pathways, impact directly or indirectly 
on the expression of several hematopoietic transcription factors in the presump-
tive hematopoietic cells in different hematopoietic sites and stages of development. 
The transcription factors directing hematopoietic fate and blood cell production 
include SCL, Gata2 and Runx1, amongst others. The specific temporal and spatial 
sequence of extrinsic signals, the combination and/or the levels of extrinsic signals 
play a role in the differential transcription factor expression and production of the 
distinct waves of hematopoietic cells in the developing embryo.
1.3.1 Intrinsic regulators of hematopoiesis
 Intrinsic regulation of HSC generation and differentiation is performed 
through downstream effectors/genetic programs directed in their expression by 
pivotal hematopoietic transcription factors. Most transcription factors act specifi-
cally through the recognition of DNA sequences associated with the non-coding 
regions of target genes. Transcription factors act as single units or in complexes in 
combination with other proteins (other transcription factors, co-factors, chromatin 
remodelers, histone acetylases or deacetylases etc). Transcription factors act direct-
ly on promoter regions or indirectly through enhancer regions, leading to positive 
or negative effects on target gene transcription. The temporal and spatial expres-
sion patterns of transcription factors, especially during embryonic development, as 
well as their expression levels/dosage have been proven to play a significant role 
in regulation of the hematopoietic program affecting cellular identity, growth and 
physiologic function.
 Several of the major transcriptional regulators of HSC specification and HSC 
generation have been identified and include the Tal1 (Porcher, Swat et al. 1996; 
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Robb, Elwood et al. 1996), Gata2 (Tsai, Keller et al. 1994) and Runx1 (Okuda, van-
Deursen et al. 1996; Wang, Stacy et al. 1996) transcription factors. Initially identi-
fied through chromosomal translocations and dysregulated expression in leukemic 
cells (Runx1 and Scl), these hematopoietic transcription factors were found to play 
pivotal roles through genetic deletion approaches in the mouse. Germ line deletion 
of each of these genes, Scl, Gata2 and Runx1, leads to midgestation embryonic 
lethality and profound anemia. Interestingly, these factors appear to work in com-
plexes that bind to regulatory regions in a large overlapping set of hematopoietic 
specific genes (Wilson, Foster et al. 2010).
 Below I discuss some characteristic examples of transcription factors with 
important roles in hematopoietic development, maintenance and differentiation. 
As major regulators of HSC generation, the Scl, Gata2 and Runx1 transcription fac-
tors are described in detail. Other factors such as Fli-1, PU.1, Gfi1 and Lmo2, that 
play specific roles in hematopoiesis, are briefly described.
1.3.1.a Scl
 The Scl (Scl/TAL-1/TCL-5) transcription factor is characterized by a basic 
helix-loop-helix domain (bHLH). As a member of the bHLH protein family, it acts 
through the HLH domain in a heterodimerization complex with E-proteins that rec-
ognize specific DNA sequences called E-box motifs (G/ACANNTGG/A) (Lecuyer and 
Hoang 2004; Murre 2005). Whereas Scl is most commonly known for its activity in 
acute T-cell leukemias (reviewed by (Begley and Green 1999)), the importance of 
Scl in normal hematopoiesis is still under research, using approaches that include 
germline and conditional deletion of the transcription factor in embryonic stem (ES) 
cells and mice.
 Scl germline deficient mice show early embryonic lethality at E9.5, with an 
absence of hematopoiesis. This extensive anemic phenotype is also thought to be 
the cause of death of these embryos. No primitive or definitive hematopoietic cells 
are produced, yolk sac vasculature is abnormal and no vitelline vessels are formed 
(Robb, Lyons et al. 1995; Shivdasani, Mayer et al. 1995; Robb, Elwood et al. 1996) . 
Scl is required for hematopoietic specification in ventral mesoderm or “hemangio-
blast‟ generation (wave 1). Its requirement for the subsequent 2nd and 3rd waves 
of mouse hematopoietic development is as yet unknown. The contribution of Scl-/- 
ES cells to the formation of mouse chimeras has also been tested. Scl-/- ES cells do 
not contribute to the formation of hematopoietic tissues, whereas they contribute 
to other various tissues. Further studies in this chimeric context proved Scl to be es-
sential for lymphoid development (Porcher, Swat et al. 1996). An in vitro approach 
has been followed to test the hematopoietic potential of Scl-/- ES cells. These cells 
show a complete lack of myeloid and erythroid hematopoiesis, an effect that can 
be rescued by retroviral introduction of Scl cDNA in these cells or by tamoxifen in-
ducible Scl expression (Porcher, Swat et al. 1996; Robb, Elwood et al. 1996; Endoh, 
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Ogawa et al. 2002).
 Scl is normally expressed in the developing embryo in hematopoietic, endo-
thelial and neural tissues. Expression in endothelial cells and hematopoietic tissues 
is of particular interest because of the developmental connection of these two cell 
lineages (hemangioblast, hemogenic endothelium) (Kallianpur, Jordan et al. 1994; 
Elefanty, Begley et al. 1999). Several studies demonstrate the specific role of Scl in 
the proper development of both endothelial and hematopoietic cell lineages (re-
viewed by  (Lecuyer and Hoang 2004) and suggest that it functions at the interface 
between vascular endothelial and hematopoietic lineages. Lancrin et al. found that 
Scl-/- Flk1+ ES-derived cells were unable to generate blast colonies (hemangioblasts) 
and also that there was a complete lack of cells expressing hematopoietic markers 
c-kit and CD41, indicating that Scl is critical for the generation of the hemogenic en-
dothelial population. Further studies by this group places its role in hematopoietic 
hematopoietic specification before the Runx1 requirement (Lancrin, Sroczynska et 
al. 2009) (see below). Differentiation studies in Zebrafish embryos and in ES cells 
show that Scl is a regulator of mesodermal patterning (Ismailoglu, Yeamans et al. 
2008; Peterkin, Gibson et al. 2009). Scl serves as an indirect negative regulator of 
cardiogenesis, and this function is independent of its later role in hematopoietic 
differentiation (Schoenebeck, Keegan et al. 2007; Van Handel, Montel-Hagen et al. 
2012). Thus, Scl plays an important role in the presumptive hematopoietic progeni-
tor/stem cell mesoderm during embryonic development (Hall, Curtis et al. 2003; 
Mikkola, Klintman et al. 2003; Van Handel, Montel-Hagen et al. 2012).
 To define the effects of Scl deletion in adult mice, conditional knock out 
approaches have been taken, circumventing the embryonic lethality resulting from 
its germline deletion. When deleted in the adult, lineage-specific effects of Scl de-
ficiency are found in erythroid cells and megakaryocytes, but not other myeloid 
lineage cells. Interestingly, Scl participates in a “core transcriptional network” (to-
gether with Gata1 and Klf1) to regulate erythroid lineage differentiation (Wontakal, 
Guo et al. 2012). It has been shown to be a direct regulator of a large group (>300) 
of erythroid specific genes, such as Eklf1, Gata1, glycophorin A, c-kit and globin 
(Kassouf, Hughes et al. 2010). Another study has revealed that Scl, through the tran-
scriptional regulation of the cell cycle controller p21, regulates megakaryopoiesis. 
Importantly, although HSCs (and multipotent progenitors) express Scl, they do not 
rely on it for their ability to self-renew, differentiate and long-term reconstitute the 
blood system of irradiated adult recipients (Mikkola, Klintman et al. 2003). The ap-
parent lack of effect of Scl deletion on adult HSCs is due to its redundancy with Lyl1 
(Souroullas, Salmon et al. 2009). Recent findings indicate that the levels of Scl ex-
pression control adult HSC quiescence by restricting the G1 entry of dormant HSCs 
(Lacombe, Herblot et al. 2010).
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1.3.1.b Gata2
 The Gata2 transcription factor which plays a role during the development 
of hematopoietic progenitor and stem cells is a member of the Gata family of fac-
tors. The 6 evolutionarily conserved proteins - Gata1 to Gata6 - recognize and bind 
the A/TGATAA/G DNA sequence from which they take their name, and have two 
highly conserved zinc finger (ZnF) domains (Ko and Engel 1993). Gata1, 2 and 3 are 
relevant to the hematopoietic system – Gata1 for the erythroid lineage, Gata2 for 
hematopoietic stem and progenitor cells, and Gata3 for T lymphocytes.
 The expression pattern of Gata2 in the mouse embryo provides some infor-
mation on its importance in the hematopoietic development. It is highly expressed 
in hematopoietic cells of the fetal liver, placenta and in endothelial cells includ-
ing the endothelium of the dorsal aorta from which HSCs emerge and intra-aortic 
hematopoietic cluster cells (Ng, George et al. 1994; Nardelli, Thiesson et al. 1999; 
Minegishi, Suzuki et al. 2003; Robert-Moreno, Espinosa et al. 2005). Moreover, high 
levels of Gata2 mRNA are detected in cell populations enriched for HSCs (Orlic, An-
derson et al. 1995). It is also expressed in the central nervous system (CNS) and fetal 
heart.
 The importance of Gata2 in the process of HSC generation was first high-
lighted by the creation of Gatat2 deficient mice. Gata2-/- embryos exhibit embry-
onic lethality between E10-E10.5 and are characterized by severe anemia (Tsai, 
Keller et al. 1994). Primitive hematopoietic progenitor numbers are decreased. 
Definitive hematopoietic progenitors are most profoundly affected and no HSCs 
are produced (Ling, Ottersbach et al. 2004). The rescue of this lethal Gata2-/- phe-
notype by functional complementation was performed using a YAC clone bearing 
the murine Gata2 genomic locus (Zhou, Lim et al. 1998). Further experiments per-
formed with Gata2-/- ES cells differentiated into EBs under specific hematopoietic 
conditions, examined the hematopoietic progenitor compartment. The greatly re-
duced number of definitive hematopoietic progenitors and their poor expansion 
capacity lead to the conclusion that Gata2 is required for proliferation and survival 
of early hematopoietic cells (Tsai and Orkin 1997). Analysis of ES cell chimeric mice 
reveals a lack of contribution of Gata2-/- cells to any hematopoietic tissue (Tsai, 
Keller et al. 1994). Interestingly, Gata2+/- embryos are greatly reduced in AGM HSC 
numbers, as shown by transplantation experiments (Ling, Ottersbach et al. 2004). 
In these studies the number of Ly6A-GFP cells, in which the HSC population can be 
found, is decreased 10 fold. However, by the time such animals reach adulthood the 
number of HSCs is normal but they are qualitatively impaired, as shown in competi-
tive transplantation assays. Thus, Gata2 plays several distinct roles during develop-
ment - HSC production, expansion and potency.
 Putative genome-wide target genes of Gata2 have been described recently
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in the hematopoietic progenitor cell line HPC-7. In genes important for hematopoi-
esis, Gata2 binding sites overlap with those of other transcriptional factors (such as 
Scl, Runx1, Lmo2, Lyl1, Fli-1 and Erg), implying the collaboration of these factors in 
a “heptameric” transcription factor complex (Wilson, Foster et al. 2010), although 
the physical interaction of all these transcription factors still needs to be verified by 
mass spectrometry. Another study in bone marrow progenitor cell populations sug-
gests that Gata2 and Scl function in combination with Ldb1, another transcriptional 
factor essential for hematopoiesis (Li, Jothi et al. 2011).
 Although, the Gata2-/- mouse studies provide unequivocal proof that Gata2 
is one of the key players in hematopoiesis, the precise function of this protein is still 
uncertain. Retroviral driven Gata2 overexpression in adult bone marrow hemato-
poietic progenitor cells blocks their ability to contribute to hematopoiesis as well as 
their ability to expand (Persons, Allay et al. 1999). Gata2/ER enforced expression in 
FDCP cells (hematopoietic progenitor cell model) and in BA/F3 cells (IL-3 dependent 
hematopoietic progenitor cell line) triggers differentiation to monocyte and granu-
locyte cell fate, while it blocks self-renewal potential (Heyworth, Gale et al. 1999).
These results reveal varying roles for Gata2 in multipotent hematopoietic progeni-
tors and suggest that Gata2 levels make the difference. Particularly in embryonic 
development, the diploid dose of Gata2 is required to make the normal number of 
HSCs (Ling, Ottersbach et al. 2004). The ability to reach the threshold level of Gata2 
expression is probabilistic in the haploid context, thus much fewer HSCs are gener-
ated. Recently, GATA2 haploinsufficiency has been found to underlie some human 
immunodeficiency syndromes (Bresnick, Katsumura et al. 2012). The researchers 
showed in a mouse model that mutations in a specific cis- regulatory element of 
Gata2 genomic locus disrupts vascular integrity in vivo and also results in a reduc-
tion of the number of HSCs and progenitors, while leaving unaffected the primitive 
hematopoiesis. This is thought to occur by preventing the positive autoregulation 
of Gata2 on its own locus due to the disruption of the Gata binding motif (John-
son, Hsu et al. 2012). Additionally, the effect of Gata2 in the growth suppression 
of hematopoietic progenitor cells may be explained by the formation of different 
complexes with other transcription factors that are expressed during later develop-
mental stages (Ezoe, Matsumura et al. 2002). Despite progress in understanding the 
function of Gata2, its exact role in HSC generation still needs further investigation.
1.3.1.c Runx1
 Runx1 (AML1, Cbfα) belongs to the family of the DNA binding proteins that 
also includes Runx2 and Runx3. These transcription factor genes have high homolo-
gy with the Drosophila gene runt (reviewed in (Swiers, de Bruijn et al. 2010). Runx1 
binds directly to the DNA sequence TGT/CGGT through its Runt homology domain 
(RHD), a 118 amino acid domain centrally located in the protein. Runx1 heterodi-
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merizes with Cbfβ to form the core binding factor (CBF). This interaction increases 
its affinity for the DNA consensus sequence (Wang, Wang et al. 1993; Wang, Stacy 
et al. 1996).
 The high frequency of chromosomal rearrangements in the Runx1 (AML) lo-
cus in acute myeloid leukemia (AML) cells was one of the reasons that made Runx1 
an interesting subject for intense study in the blood system (reviewed by (Rabbitts 
1994)). Runx1 binds to the regulatory elements (enhancer core motifs) and pro-
vides for tissue specific gene expression of molecules known to be important for he-
matopoiesis. Some of these genes encode GM-CSF, IL-3 and CSF1 receptor (Okuda, 
vanDeursen et al. 1996).
 The importance of Runx1 in the development of the hematopoietic system 
was first revealed in Runx1 deficient mice (Okuda, vanDeursen et al. 1996). Deletion 
of this transcription factor results in severe hematopoietic defects that lead to em-
bryonicembryonic lethality at E12.5. In contrast the early normal production of the 
primitive hematopoietic system, the most obvious effect of Runx1 deficiency is the 
complete absence of definitive hematopoiesis in the yolk sac (YS) and the fetal liver 
(FL) at midgestation. The AGM region was found to contain no HSCs (Cai, de Bruijn 
et al. 2000). Lack of contribution to the hematopoietic tissues by Runx1-/- cells was 
also observed in chimeric mice made with Runx1-/- ES cells. EB differentiation of 
Runx1-/- ES cells and analysis for the presence of hematopoietic progenitors con-
firmed the lack of definitive hematopoiesis (Okuda, vanDeursen et al. 1996; Wang, 
Stacy et al. 1996; Mukouyama, Chiba et al. 2000). Interestingly, deficiency of core 
binding factor β (Cbfβ), the partner of Runx1 in the core binding factor complex 
(CBF), results in the same phenotype as Runx1 deficiency (Sasaki, Yagi et al. 1996; 
Wang, Stacy et al. 1996; Wang, Stacy et al. 1996).
 The temporal and spatial expression pattern of Runx1 argues for its impor-
tance in the generation of the HSCs and progenitor cells. Runx1 expression local-
izes to the endothelial cells of the yolk sac, the vitelline and umbilical arteries, the 
chorio/allantoic placenta and most importantly the ventral wall of the dorsal aorta 
(North, Gu et al. 1999; Ottersbach and Dzierzak 2005; Zeigler, Sugiyama et al. 2006; 
Rhodes, Gekas et al. 2008). It is expressed in the aorta just before the emergence of 
the HSCs and the progenitor cells, implicating Runx1 in the hematopoietic fate pro-
cess in hemogenic endothelial cells. Evidence to support this theory showed that 
Runx1-/- embryos lack hematopoietic clusters and ex vivo cultures of Runx1-/- en-
dothelial cells possess no hematopoietic potential (North, Gu et al. 1999; Yokomizo, 
Ogawa et al. 2001). A more recent study (Chen, Yokomizo et al. 2009) confirmed the 
specific role of Runx1 in the generation of hematopoietic cells from the hemogenic 
endothelial cells. Specific deletion of Runx1 in VE-cadherin (VEC) expressing endo-
thelial cells (VEC-Cre mediated Runx1 excision) resulted in lack of HSC and progeni-
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tor generation, phenocopying the hematopoietic defects found in the germline de-
leted embryos. Interestingly, the specific deletion of the gene in a hematopoietic 
cell context (Vav-cre mediated Runx1 excision) showed that Runx1 is no longer re-
quired after HSCs are generated. Thus, Runx1 plays an important role in the endo-
thelial to hematopoietic transition process by which definitive progenitors and HSCs 
are generated. However, although it is expressed in HSCs after they are generated, 
Runx1 function is no longer required.
 Similarly to Gata2, haploinsufficiency of Runx1 has notable effects on HSC 
generation. A haploid dose of the transcriptional factor leads to only half the num-
ber of HSCs in the AGM region (Cai, de Bruijn et al. 2000; Robin, Ottersbach et 
al. 2006). It also results in the slightly earlier appearance of HSCs in the normal 
sites of hematopoiesis in the embryo (Cai, de Bruijn et al. 2000). Haploinsufficiency 
and trisomy of Runx1 (on chromosome 21) in man predisposes the individual and/
or results results in hematopoietic dysfunction (leukemia and Downs Syndrome). 
Thus, proper regulated control of transcription factor levels in HSCs is an important 
but often less studied aspect. An interesting experiment to test whether Gata2 and 
Runx1 function in the same cells (precursors, hemogenic endothelial, hematopoi-
etic cells) was performed. Since adult Runx1+/- and Gata2+/- mice are viable and 
present with a relatively normal hematopoietic blood profile, matings were estab-
lished to generate double heterozygous mice. Interestingly, no Runx1+/-:Gata2+/- 
mice were born. However, Runx1+/-:Gata2+/- embryos could be harvested and fetal 
livers were found to contain fewer hematopoietic progenitors than single hetero-
zygous mutants (Wilson, Foster et al. 2010) Chapter 4, this thesis). These findings, 
together with chromatin immunoprecipitation studies in hematopoietic cell lines, 
strongly suggest that Runx1 and Gata2 act in concert to control expression of hema-
topoietic genes involved in HSC and progenitor cell generation.
1.3.1.d Other Factors
 Fli-1 is a member of the Ets transcription factor family. It has been found to 
be involved in human erythroid cell differentiation by affecting self renewal of ery-
throid progenitor cells. Reduced expression of Fli-1 drives differentiation of pluripo-
tent hematopoietic progenitor cells and its overexpression results in inhibition of 
erythroid differentiation [(Howard, Yousefi et al. 1993; Athanasiou, Mavrothalassitis 
et al. 2000) and review by (Perry and Soreq 2002)]. Furthermore, Fli-1 deletion has 
been connected with dysmegakaryopoiesis and in combination with more evidence 
render it as a positive regulator of megakaryopoiesis [(Hart, Melet et al. 2000; Spy-
ropoulos, Pharr et al. 2000; Kawada, Ito et al. 2001; Jackers, Szalai et al. 2004) and 
review by (Szalai, LaRue et al. 2006)].
 PU.1 is another member of the Ets transcription factor family that partici-
pates in the control of hematopoietic differentiation. PU.1-/- mice show embryonic 
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lethality late in gestation with a fetal liver deficiency of B lymphocytes, granulocytes 
and macrophages (Scott, Simon et al. 1994; McKercher, Torbett et al. 1996; Llober-
as, Soler et al. 1999; Back, Dierich et al. 2004). It has been suggested that expression 
levels of PU.1 in hematopoietic progenitor cells regulate their lineage commitment 
(Singh, DeKoter et al. 1999; DeKoter and Singh 2000). Interactions of PU.1 with dif-
ferent partners and formation of different protein complexes explain the ability to 
perform different functions [review in (Gupta, Gurudutta et al. 2009)].
 Growth factor independence 1 (Gfi1) gene is expressed in several types of 
blood cells. First of all it is expressed in HSCs and in subsets of T-cells, granulo-
cytes, monocytes and macrophages (Karsunky, Zeng et al. 2002; Hock, Hamblen et 
al. 2004; Yucel, Kosan et al. 2004). Gfi-1 germline deficiency in mice leads to neutro-
phil ablation and to an HSC population with only short term hematopoietic activity 
((Zeng, Yucel et al. 2004) and review by (Wilson, Calero-Nieto et al. 2011)). Recent 
data from the Lacaud lab suggest that Gfi1 is involved in directing the morphologic 
changes that hemogenic endothelial cells undergo in the endothelial to hematopoi-
etic transition (ISEH abstract).
 Lmo2 is an example of a transcriptional cofactor that works in collaboration 
with several important hematopoietic transcription factors (like Gata1, Gata2, Scl/
Tal1). It has been shown that Lmo2 is essential for erythroid development and also 
in adult hematopoiesis. Germline deficiency leads to embryonic lethality with fail-
ure of YS erythropoiesis (Warren, Colledge et al. 1994; Yamada, Warren et al. 1998). 
It does not bind to the DNA directly but after the formation of protein complexes 
with other transcription factors like SCL/Tal1, Gata1 and Gata2 [review by (Wilson, 
Calero-Nieto et al. 2011)]. The formation of different transcription factor complexes 
explains the distinct roles and functions of the protein in different cell populations 
(review in (Wilson, Calero-Nieto et al. 2011) and (Loose, Swiers et al. 2007)).
1.3.2 Extrinsic regulation of HSC generation
 Apart from transcription factors, extrinsic regulation, through extracellular 
signaling, plays an important role in the control of HSC generation. The study of 
the hematopoietic niches and the microenvironment of the hematopoietic sites has 
provided insight into the signals and signaling pathways participating in the control 
of HSC generation. Some of the identified signaling pathways are BMP, Notch, TGFβ, 
Hedgehog and Wnt.
 Hedgehog (Hh) signaling has a role in hematopoiesis and its role might 
differ depending upon the developmental stage (embryo or adult), the cell type 
(mature hematopoietic cells and HSCs) and the conditions (physiologic homeostasis 
and stress hematopoiesis) (Lim and Matsui 2010). Through studies in mice and ES 
cells it has been suggested that Hedgehog (Hh) has a role in vasculogenesis and 
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primitive hematopoiesis (Dyer, Farrington et al. 2001; Byrd, Becker et al. 2002).  In 
contrast, Gering et al. have shown in zebrafish that Hh signaling is involved in defini-
tive but not primitive hematopoiesis and they suggest that it plays distinct roles in 
embryonic development depending on the downstream mediators of Hh signaling. 
More zebrafish studies show that Hh acts in a polarizing manner in the dorsal part 
of the dorsal aorta in maintaining the arterial program and in an opposing manner 
with Bmp signaling which acts on the ventral side of the dorsal aorta (Wilkinson, 
Pouget et al. 2009). Mouse embryo studies in our laboratory have shown that Hh 
expression from the gut tissue (ventrally located from the dorsal aorta) induces the 
HSC activity of E10 AGM. The same result has also been achieved by exogenous ad-
dition of Hh (Peeters, Ottersbach et al. 2009).
 Another signaling molecule with a role in hematopoiesis is bone morpho-
genetic protein 4 (BMP4). In the mouse embryo, BMP4 is expressed in the mesen-
chyme ventrally of the DA and it has been suggested that it has a direct effect on 
the HSCs since BMP4 receptors (BMP4R) are expressed in an enriched HSC popula-
tion (Durand, Robin et al. 2007). Furthermore, in vitro studies with hematopoietic 
differentiation of ES cells have revealed that BMP4 regulates differentiation of ES 
cells into cells with hematopoietic potential (Johansson and Wiles 1995; Chadwick, 
Wang et al. 2003). Dose-dependent effects on the role of BMP4 at the prolifera-
tion and differentiation of primitive human hematopoietic cells have also been de-
scribed. Low levels of BMP-4 seem to induce proliferation and differentiation of this 
cell population while higher levels maintain the cells in a quiescent state (Bhatia, 
Bonnet et al. 1999). Experiments performed on Xenopus and zebrafish indicate that 
BMP signaling induces Fli1 expression which acts upstream of other specific hema-
topoietic transcription factors such as Gata2, Scl, Lmo2 and Etsrp.
 Notch is another signaling pathway controlling various developmental pro-
cesses. Different members of the Notch family seem to have different effects in 
embryonic development. Notch2, Notch3 and Notch4 have been shown to affect 
vasculogenesis while Notch1 has been implicated with hematopoiesis [(Joutel, Cor-
pechot et al. 1996; Krebs, Xue et al. 2000; McCright, Gao et al. 2001; Kumano, Chiba 
et al. 2003) and review by (Bigas, Robert-Moreno et al. 2010)]. It has been shown by 
studies in Notch1-/- embryos that the deficiency for Notch1 effects only definitive 
but not primitive hematopoiesis since the number of hematopoietic progenitors 
in the YS of Notch1-/- embryos is similar to the number in WT embryos [(Kumano, 
Chiba et al. 2003) and review by (Bigas, Robert-Moreno et al. 2010)]. It was further 
proposed by this study is that Notch1 plays a role in the endothelial to hematopoi-
etic transition and acquisition of hematopoietic fate from hemogenic endothelial 
cells. These findings are strengthened by RBPjκ/CSL mutant (Robert-Moreno, Espi-
nosa et al. 2005) and Jagged deficient embryos (Robert-Moreno, Guiu et al. 2008). 
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It has been proposed that these effects of Notch1 signaling are mediated by the 
regulation of Gata2 expression. This suggestion is supported by the fact that the 
presumptive hematopoietic cells located ventrally in the aorta expressing Gata2 
also highly express Notch1. In zebrafish studies it has also been shown that Runx1 
is a target of Notch1 signaling with an effect on hematopoiesis (Burns, Traver et 
al. 2005; Bugeon, Taylor et al. 2011). Apart from effects in the generation of HSCs 
Notch signaling pathways also participate in other hematopoietic specific processes 
like HSCs self renewal, lymphoid and myeloid differentiation as well as in the de-
velopment of the vascular network [review by (Bigas, Robert-Moreno et al. 2010)].
1.4 Scope of the thesis
 Blood generation during mouse embryogenesis is a very complex and tight-
ly regulated process. It happens in three waves, that can be temporally, spatially as 
well as functionally distinguished from each other. The third wave of hematopoiesis 
is characterized by the generation of HSCs from hemogenic endothelial cells. The 
HSCs are the most important cells of the adult hematopoietic system since they can 
provide an organism with all the different cells of the blood tissue during its lifes-
pan.  The regulation of HSC generation is the result of the combination of several 
extrinsic and intrinsic signals. Several of these signals, including cytokines, growth 
factors and transcription factors, have already been described. What is still lacking 
is an understanding of the exact molecular events and their interplay in the control 
of HSC emergence, expansion and differentiation.
 The focus of this thesis is on the transcription factor Gata2 and its role in 
HSC generation and growth. To date it has not been possible to detect and examine 
Gata2 expressing cells in vivo and also sort them and test their potential in vitro. 
Only in this way is it possible to understand the role of this pivotal HSC transcrip-
tion factor in the process of HSC generation. To address this need and study Gata2 
expression in live imaging experiment I generated a new Gata2 reporter ES cell line 
and mouse model that facilitates the identification and isolation of Gata2 express-
ing cells. In these studies I explore the potential of the Gata2 expressing cell popula-
tions so as to understand the role of the transcription factor in embryonic hemato-
poiesis.
 In the second chapter we describe the generation of an ES cell Gata2-Venus 
reporter line. The ES cell differentiation system is used as a model of embryonic 
hematopoietic development in order to test the potential of the Gata2 expressing 
cells. We show that the Gata2 expressing cell population is highly enriched in he-
matopoietic progenitors and that Gata2 expressing cells also have endothelial po-
tential. In the third chapter, we describe the generation of a Gata2-Venus reporter 
mouse model. The major advantage of our mouse model is that it does not interfere 
with Gata2 expression levels or function. Using these reporter mice we show that 
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Venus expression recapitulates Gata2 expression in the embryo, rendering our re-
porter mouse a suitable model for the prospective isolation of Gata2 expressing 
cells and testing their potential in in vivo and in vitro functional assays. We show 
that Gata2 expressing cell fraction is highly enriched in hematopoietic progenitors. 
We also identify a Gata2 independent progenitor population. Finally, we show that 
the HSC activity can be found only in the Gata2 expressing cell fraction. In chapter 4, 
the genome-wide binding profile of ten important transcriptional regulators of he-
matopoiesis is presented. Bioinformatics analysis of these data sets provides com-
prehensive genome-wide combinatorial interactions between these key regulators 
and suggests the existence of a heptamere of transcription factors associated with 
HSCs and progenitor cells. Some of these protein-protein interactions were previ-
ously unrecognized. In vivo evidence that two of the central hematopoietic regula-
tors (Runx1 and Gata2) work in the same cells is also provided. This study gives a 
good a good example of how bioinformatics analysis of genome-wide binding profil-
ing of several transcription factors can provide new insights into understanding how 
transcription factors cooperate in the regulation of specific cell processes.
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Abstract
 The process of embryonic hematopoiesis is tightly controlled by a combina-
tion of extracellular signals as well as intracellular regulators such as transcription 
factors. An understanding of this developmental process is of high importance for 
the field of hematopoiesis. Detailed descriptions of the molecular events regulating 
the generation of hematopoietic cells could provide us with new options for the 
successful generation and manipulation of hematopoietic stem cells (HSCs) in vitro. 
It has already been demonstrated that the hematopoietic cells are derived from a 
type of progenitor with both endothelial and hematopoietic potential (hemangio-
blast) and from specialized endothelial cells with hematopoietic potential (hemo-
genic endothelium). The transition between these developmental stages is under 
intense investigation.
 Several transcription factors have been described having specific and im-
portant effects in the generation of HSCs. Gata2 is considered to be one of the 
master regulators of hematopoiesis, since its deletion leads to embryonic lethality 
due to severe hematopoietic defects. The specific role of Gata2 in this process has 
not been defined yet.
 The embryonic stem cell (ES) differentiation system, in which embryoid 
bodies (EB) are formed, is a suitable in vitro model that recapitulates the early em-
bryonic development and has already been used to study of the role of some tran-
scription factors in hematopoietic development. In this study we report the gen-
eration and characterization of a novel ES cell reporter line (Gata2-Venus). We find 
that Venus is expressed coordinately with Gata2. For the first time Gata2 expressing 
cells can be directly sorted and tested for lineage potential in functional assays. We 
show that the Gata2 expressing cell population is highly enriched in hematopoietic 
potential and also possesses endothelial potential.
Introduction
 The in vitro differentiation of embryonic stem (ES) cells into embryoid bod-
ies (EB) has been widely used as a model to study embryonic hematopoiesis.  Spe-
cific culturing conditions have been successfully described for the differentiation of 
EB derived cells into the different and distinct types of hematopoietic progenitors. 
The developmental kinetics of the different progenitor types parallels that of the 
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early embryo, particularly yolk sac hematopoiesis (Keller, Webb et al. 2002; Choi, 
Chung et al. 2005). Blast colony forming cells (BL-CFCs), a cell type with hemangio-
blast characteristics, appear first (Kennedy, Firpo et al. 1997; Choi, Kennedy et al. 
1998), followed by the development of primitive erythroid and later on definitive 
erythroid and myeloid progenitors (Wiles and Keller 1991; Nakano, Kodama et al. 
1996; Palis, Robertson et al. 1999). Lymphoid differentiation from EB derived cells 
has also been successfully described, with the differentiation to B, NK and T-lineage 
cells (Nakano, Kodama et al. 1994; Tabatabaei-Zavareh, Vlasova et al. 2007). Where-
as most distinct lineages of differentiated blood cells can be produced in this in vitro 
model, it has not yet been possible to obtain adult-type transplantable hematopoi-
etic stem cells (HSCs) without genetic manipulation.
 The developmental similarities between the early stage conceptus and the 
EB differentiation culture system offer some significant practical advantages. This 
system provides access to various distinct cell types representing different stages 
of hematopoietic development. These cell types can be easily identified, character-
ized and isolated in sufficient numbers for genetic and epigenetic analysis, some-
thing not feasible in an in vivo embryo system because of cell number limitations. 
Moreover, ES cells can be easily manipulated to study the effects of specific genes 
in the process of embryonic hematopoiesis. ES cell gene targeting has been used 
to produce deletions and mutations in genes regulating hematopoietic progenitor/
stem cells, such as SCL, Gata2 and Runx1 (Tsai, Keller et al. 1994; Porcher, Swat et 
al. 1996), as well as lineage-specific regulators function like Gata1 (Weiss, Keller 
et al. 1994). Studies with SCL-/- ES cells have shown that this transcription factor is 
required for the specification of hemangioblasts during EB differentiation. 
 In this study we investigated the role of Gata2 in hematopoietic develop-
ment. The importance of the Gata2 transcription factor in hematopoietic devel-
opment has been highlighted in several in vitro and in vivo models. Gata2-/- mice 
die during development at embryonic day (E)10 – E10.5 of gestation. These mice 
show severe anaemia and complete absence of definitive hematopoietic progeni-
tors. Furthermore, chimeric studies with Gata2-/- ES cells showed no contribution of 
these cells to any hematopoietic tissue (Tsai, Keller et al. 1994). Apart from these 
functional experiments, Gata2 localization studies have shown expression of Gata2 
in hematopoietic tissues at most developmental timepoints. A characteristic exam-
ple is the expression of Gata2 in the endothelial cells forming the wall of the dorsal 
aorta, the first site of autonomous generation of the HSCs in the mouse embryo 
(Kornhauser, Leonard et al. 1994; Ng, George et al. 1994; Minegishi, Ohta et al. 
1998; Nardelli, Thiesson et al. 1999; Robert-Moreno, Espinosa et al. 2005). Another 
characteristic of pivotal transcription factors in hematopoietic development is the 
connection between expression levels of the protein and its function. Mice hetero-
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zygous for Gata2 have reduced Gata2 expression and show a greatly reduced num-
ber of hematopoietic progenitors (Ling, Ottersbach et al. 2004), demonstrating that 
precise levels of this transcription factor in generation or expansion of the HSC pool. 
What is lacking in these models is the ability to directly isolate Gata2 expressing 
cells.
 To prospectively study the role of Gata2 during hematopoietic development, 
we generated a Gata2-Venus fluorochrome ES cell reporter cell line. We report here 
the generation of a 3’UTR Gata2 targeting construct that allows expression of an 
IRES Venus gene concomitantly with normal levels of Gata2. This approach avoids 
Gata2 haploinsufficiency. Our results show proper, coordinately regulated expres-
sion of Gata2 and Venus. We show that almost all EB-derived hematopoietic pro-
genitors are Gata2 expressing, whereas endothelial cells are both Gata2-expressing 
and non-expressing. These ES cells represent a unique resource for further genetic 
and epigenetic studies of hematopoietic development.
Results
Gata2-Venus ES cell generation
 To better understand the role of the Gata2 transcription factor in the em-
bryonic generation of definitive progenitors and stem cells, we established a mouse 
ES cell model that would allow the tracking of Gata2 expression and the prospec-
tive isolation of Gata2 expressing cells during hematopoietic cell development.  A 
knock in approach was followed, whereby the coding sequence for the Venus fluo-
rochrome preceded by an IRES sequence was recombined into the 3’ UTR of the 
Gata2 genomic locus (fig 1A). A LoxP flanked puromycin gene was included in the 
construct for positive selection. Using this strategy, the Gata2 coding sequence is 
preserved, avoiding Gata2 haploinsufficiency and negative effects on hematopoi-
etic development. Moreover, the expression of the fluorochrome will not interfere 
with Gata2 protein function, as may be the case with the use of a Gata2-Venus fu-
sion protein.
 Gata2-Venus targeting was performed in ES cells, followed by puromycin 
selection. 460 ES clones were expanded. DNA was isolated from each clone and PCR 
for the targeting construct was performed. Six clones were found to contain the tar-
geting construct and these were further screened by Southern blotting analysis (fig 
1B), to ensure the correct integration into the 3’UTR of the Gata2 genomic locus. 
Two positive clones showed the proper integration of the construct and these were 
karyotyped. One of them had the normal number of chromosomes and was used in 
the rest of the studies presented here.
 To minimize the potential effects of the inserted construct on proper regu-
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lation of Gata2 expression, we excised the puromycin selection cassette. A diffusible 
Cre protein was added directly into ES cell cultures (Peitz, Pfannkuche et al. 2002; 
Peitz, Jager et al. 2007) for 18 hours. Thereafter, ES cells were plated as single cells 
and allowed to expand in culture. Individual clones were analyzed for recombina-
tion excision events by DNA PCR designed to detect the presence of the LoxP site 
(fig 1C).  Two clones (G2V5 and G2V6) that had excised the puromycin selection cas-
sette were found. G2V5 was used for the experiments described in further studies.
Fig 1 Generation of Gata2-Venus reporter ES cell line
 The Gata2-Venus targeting construct is designed so that a full length Gata2 protein 
and Venus fluorochrome are produced by a bicistronic mRNA transcript. (A) Mouse Gata2 
genomic locus (top). Exons 1-6 depicted as orange boxes and STOP codon position is indi-
cated. Predicted structure and restriction map of Gata2-Venus targeting construct (middle). 
Homology borders between wild type Gata2 genomic locus and Gata2 targeting construct 
are highlighted.  Triangles represent LoxP sites. The positions of the restriction sites used 
in the cloning strategy are indicated. Corresponding boxes for the IRES-Venus and the PGK-
Puro selection cassette are noted in the scheme. Predicted structure of the Gata2-Venus 
targeted allele after the excision of the selection cassette by Cre recombination (bottom). 
The set of LoxP flanking primers used for the detection of recombined clones are shown as 
small arrows (actual primer size not proportional with the length of the arrow). (B) Southern 
blot analysis of ES cell clones. Genomic DNA was isolated and digested with BglII. Detection 
probe was a genomic Gata2 DNA sequence (600 bp) localized upstream of the left recombi-
nation arm (not depicted). Expected fragment sizes (wt Gata2 12 Kbp; Gata2-Venus 11 Kbp). 
Lanes 1, 2, 3, 4, 5, 6, c represent ES cell clones 344, 334, 325, 195, 187, 107 and wt DNA 
control respectively. Clones 325 and 107 show the expected pattern of correct integration. 
(C) PCR reaction for the detection of the recombined clones that have excised the Puromycin 
selection cassette. In lane 1 and 2 the PCR results of clones G2V5 and G2V6 respectively are 
depicted. The upper band (278 bp) detects the recombined allele and the lower band (234 
bp) the wt one. Lane 3 shows the result of a control of a recombined mouse DNA (described 
in next chapter) and lane 4 is wt control DNA.
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Venus expression parallels that of Gata2 during EB hematopoietic differentiation
 To check whether G2V5 ES cells express the Venus fluorochrome during 
hematopoietic development, EB differentiation cultures were established. At day 
(d)5 of differentiation, G2V5 and wild type (WT) control EBs were observed under 
the fluorescent microscope (fig 2A). G2V5 EBs showed Venus expressing cells that 
specifically localize in the core of the EB.  To quantitate Venus expressing cells in 
such cultures, d6 EBs were harvested, made into a single cell suspension and tested 
by FACs analysis for Venus fluorochrome expression (fig 2B). Venus expression was 
found in approximated 3 - 4% of the d6 G2V5 EB cell population, confirming the 
Venus expression observed in whole EBs.
 To test whether the Venus expressing cells also express Gata2, we took a 
qRT-PCR approach. Venus positive and Venus negative cell fractions were flowcy-
tometrically sorted from d6 EBs and examined for Venus and Gata2 gene expres-
sion. Venus and Gata2 mRNAs were detected only in the Venus positive sorted cell 
fraction (fig 2C) demonstrating, as expected from the IRES containing construct, 
that Venus gene expression is coordinated with Gata2 gene expression. Venus and 
Gata2 protein expression in the sorted cell fractions was also examined. In accor-
dance with the mRNA data, Western blot analysis showed the presence of Gata2 
and Venus protein only in the Venus-positive sorted EB cell fraction (fig 2D). Thus, 
the 3’UTR Gata2 IRES Venus knock-in approach leads to faithful and exclusive ex-
pression of the Venus fluorochrome in Gata2 expressing cells.
 To further examine the expression of Gata2 and Venus, we performed a 
time course analysis during ES cell differentiation. EBs were harvested at different 
timepoints (d0, d2, d3, etc.) and the relative levels of Gata2 and Venus mRNA were 
tested by qRT-PCR. As shown in fig 2E there is a coordinated up- and down-regula-
tion of expression of Venus and Gata2 mRNA, indicating that both genes are subject 
to correct developmental regulation. 
 These results demonstrate that Venus fluorochrome expression is an ex-
cellent surrogate marker for Gata2 expression in the ES cell differentiation culture 
system, with G2V ES cells as a suitable in vitro model for studying the role of Gata2 
in hematopoietic development.
Venus expressing EB cells possess endothelial and hematopoietic potential
 In the mouse embryo, Gata2 is known to be expressed both in endothelial 
and hematopoietic cell lineages. We analyzed G2V5 cells for expression of Gata2 
specifically in endothelial and hematopoietic cells derived from d6 EB differentia-
tion cultures. Flow cytometric analysis for endothelial marker Flk1, endothelial and 
hematopoietic marker CD31, and hematopoietic markers c-kit and CD45 was per-
formed (fig 3A, fig 3B). A small percentage of EB-derived endothelial and hemato-
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Fig 2 Venus expression during EB differentiation
 (A) Venus fluorochrome expression in a single EB after 5 days (d5) of differentia-
tion. Brightfield and fluorescence images are depicted in left and right panel respectively. (B) 
Flow cytometric analyses of Venus expression in single cell suspensions of d6 EBs. Wild type 
(wt) control EB cells (left panel) and G2V5 EB cells (right panel). Percentages (%) of positive 
and negative cell fractions are shown. (C) qRT-PCR analysis of Gata2 and Venus expression 
by Venus positive and Venus negative sorted cell populations from G2V5 d6 EBs. Gata2 and 
Venus mRNA was detected only in the Venus positive sorted cell fraction. (D) Western blot 
analysis for Gata2 and Venus protein expression in d6 EBs. Anti-Gata2 antibody was used 
for Gata2 detection and anti-GFP antibody for Venus detection in Venus positive (+) and 
Venus negative (-) sorted cell fractions. BaF3, a Gata2 overexpressing cell line was used as 
a positive control for Gata2 expression.  Npm1 (Nucleophosmin 1) was used as a protein 
loading control. Only the Venus positive sorted cell extracts show Gata2 and Venus protein 
expression. (E) qRT-PCR analysis of Gata2 and Venus mRNA expression between d0 and d8 
of EB differentiation. Relative mRNA quantity was normalized to beta actin mRNA. On x axis 
the day of differentiation is shown. Wild type ES cells were used as negative control (ctrl) for 
Venus expression and as a positive control for Gata2 expression. Venus and Gata2 expres-
sion is coordinately regulated during G2V5 differentiation.
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poietic cells were Gata2 Venus expressing. Of the 2.5% of EB cells that were Flk1 
positive, 20% of these also expressed Gata2 Venus. CD31 positive cells represented 
14% of the total EB cell population and 10% of CD31 positive cells expressed Gata2 
Venus. No CD45 positive EB cells were found. However, of the 35% of EB cells ex-
pressing c-kit, only 0.3% expressed Gata2 Venus. The fact that only a small propor-
tion of the EB-derived hematopoietic and endothelial cells are Gata2 expressing 
suggests that Gata2 expression delineates the hematopoietic progenitors and pos-
sibly hemogenic endothelial cells.
 We next examined d6 G2V5 EBs for endothelial and hematopoietic func-
tion. To test the endothelial potential of Gata2 expressing cells, Venus positive and 
negative cells were sorted and plated in Matrigel under endothelial growth condi-
tions. Cells of both fractions showed endothelial differentiation potential. Tubules 
with matrix and junction formation typical of endothelial cells were found (fig 3C). 
Thus, some EB-derived Gata2 expressing cells are functional endothelial cells. 
 The hematopoietic function of d6 G2V EB cells was tested in methylcellu-
lose progenitor assays. Highly enriched colony-forming unit-culture (CFU-C) activity 
was found in the Gata2 expressing sorted cell population. The frequency of progeni-
tors in the Gata2 expressing cell fraction was 43-fold increased as compared to the 
Gata2 negative fraction. The vast majority of the colonies were CFU-Es, which are 
primitive erythroid lineage restricted colonies. This data matches what has been 
previously reported concerning the types of progenitors present at this stage of EB 
differentiation (Keller, Webb et al. 2002; Mikkola, Fujiwara et al. 2003; Choi, Chung 
et al. 2005), the types of progenitors lacking in Gata2-/- differentiated ES cells and 
also parallels the primitive erythroid colony formation observed with yolk sac-de-
rived cells. Other colony types indicative of granulocyte and macrophage progeni-
tors were also found,  thus suggesting a role for Gata2 in cells with  primitive and 
definitive hematopoietic potential (fig 3D).
Discussion
 We generated a novel Gata2 Venus reporter ES cell line, that expresses Ve-
nus in a temporally and lineage correct manner. The targeted insertion of the IRES 
Venus reporter into the Gata2 3’UTR rather than the coding region prevents a Gata2 
haploinsufficiency state. This is important since Gata2 haploinsufficiency results in 
a decrease in the number of the HSCs in the AGM as well as in qualitative defects 
in the adult HSCs population (Ling, Ottersbach et al. 2004). A similar targeting ap-
proach was used by others for generation of a PU.1 fluorescent reporter. The direct 
detection of PU.1 expression levels was useful in identifying functionally distinct 
common myeloid progenitors. Moreover, it was found that PU.1 downregulation is
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Fig 3 Endothelial and hematopoietic potential of Gata2 expressing cells
 Flow cytometric analysis of d6 G2V5 EB cells. (A)  Cells stained for endothelial mark-
ers Flk1 and CD31. Flk1 is also expressed on early mesodermal and hemangioblast cells. 
CD31 is also expressed on hematopoietic cells. (B) Cells stained for hematopoietic markers 
c-Kit and CD45. % of cells in each of the quadrants are shown. 20-50x103 number of events 
were analyzed. (C) Endothelial differentiation of EB derived cells. Venus + and Venus – cells 
were plated on matrigel coated dishes. Images show tubule and junction formation which 
was observed from both Venus + and Venus – cells at 2 hours (2h) and 5h after plating. (D) 
Methylcellulose colony forming unit-culture (CFU-C) progenitor assay. The frequency of pro-
genitors (CFU-C/104 cells) is presented in Venus +, Venus – and unsorted populations. The 
Venus + population shows a 43-fold enrichment of progenitors as compared to the Venus– 
population.
associated with restriction to megakaryocyte and erythroid lineage differentiation 
(Nutt, Metcalf et al. 2005). Whereas 3’UTR sequences represents accessible sites 
for gene targeting, specific sequences within the 3’UTR of many genes are target 
sites for miRNAs. Disruption of such sequences may result in aberrant gene regula-
tion. Indeed, the Gata2 3’UTR contains a miRNA target sequence. The miR-451 has 
been shown in zebrafish to regulate Gata2 expression during erythroid differentia-
tion (Pase, Layton et al. 2009) and the Gata2 gene has 2 target sequences for this 
miR. Data mining of the mouse genome predicts 3 target sites in the 3’UTR of the 
mouse Gata2 gene.  However, our construct was designed so that the insertion of 
the IRES Venus reporter does not interfere with the miRNA target sequences.
 Our Gata2-Venus ES cell reporter line allows the prospective isolation of 
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cells expressing the Gata2 transcription factor. Previously, Gata2 expression could 
be assessed only retrospectively by transcription analysis of hematopoietic progeni-
tor and stem cell populations obtained by flow cytometrically sorting for specific 
cell surface markers that characterize these cells types. Gata2 was found to be 
expressed by hematopoietic progenitors and stem cells but not by mature blood 
cells. Here we show that directly sorted Gata2 expressing d6 EB cell populations 
are 43-fold enriched in hematopoietic progenitors. Our results support a role for 
this transcription factor in EB hematopoietic progenitor potential. Additionally, we 
found that Gata2 expressing cells (and also Gata2 non-expressing cells) have endo-
thelial potential. The fact that both endothelial cells and hematopoietic progenitors 
express Gata2 suggests that Gata2 may function in the precursors to these two 
lineages, i.e. hemangioblasts and/or hemogenic endothelial cells. We are attempt-
ing to establish whether cells with these characteristics can be enriched from G2V5 
EBs. Single cell studies and live imaging of single Gata2 expressing EB cells will be 
performed to define more accurately their lineage potentials and differentiation 
properties. Prospectively isolated Gata2 expressing cells will allow further charac-
terization, such as cell cycle status, signaling pathway activation and gene expres-
sion profiling and provide insight into the possible roles of Gata2 in hematopoietic 
progenitor and stem cell development.
 A more detailed characterization of the cell population expressing Gata2 
is currently underway.  In combination with Gata2, panels of cell surface markers 
are being used to identify cells as they begin to take on hematopoietic lineage fate. 
Expression of a marker such as CD41, which is one of the earliest hematopoietic 
markers, would indicate commitment to the hematopoietic lineage (Mikkola, Fuji-
wara et al. 2003; Robin, Ottersbach et al. 2011). Expression of intermediate levels of 
CD41 would be indicative of HSC development, as has been found in the AGM. En-
dothelial cells expressing Gata2 could then be followed in real-time to observe the 
acquisition of hematopoietic stem cell potential. Another marker that is expressed 
on the hematopoietic stem cell population is Ly-6A (Sca-1). Ly-6A GFP ES cells have 
been produced and are an excellent resource to discover appropriate culture condi-
tions allowing the in vitro generation of HSCs. Onset of GFP expression should mark 
the endothelial to HSC transition, as has been observed in real-time In vivo.  Double 
fluorescent marker ES cells would facilitate a more efficient enrichment of EB cells 
with HSC potential. The use of endothelial markers such as endoglin or Tie2 could 
provide further information about possible presence of distinct endothelial cell 
types, including hemogenic endothelium, and different stages of the endothelial to 
hematopoietic transition in ES differentiation cultures, and provide candidates for 
further HSC enrichment procedures.  
 In summary, in this study we describe the generation and characterization 
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of a novel Gata2-Venus ES cell reporter line. This new system gives us the opportu-
nity to directly isolate Gata2 expressing cells during EB differentiation, study their 
lineage potential during distinct stages of differentiation and to illuminate the func-
tion of Gata2 during hematopoietic development in vitro and in vivo.
Materials and methods
Cloning strategy
 The Gata2 homology arms were amplified from either IB10 derived ge-
nomic DNA or from BACs clone containing the last exon and the 3’ UTR of the 
Gata2 genomic locus. The amplification was done using PhusionTM taq polymerase 
(Finnzymes F-530L). The left recombination arm was amplified with the use of 5’ 
AATCGATGCCGAGGGAGTTCAGTGCTAG 3’ (forward primer) and 5’ AGATATCACAGTA-
ATGGCGGCACAAGGC 3’ (reverse primer). The right recombination arm was ampli-
fied using 5’ ATACGTACAGGAAGGAAACATTCTCTGG 3’ (forward primer) and 5’ ACTC-
GAGGTCTCAGGCAAGACTATGG 3’(reverse primer)and the middle recombination 
arm with 5’ CATATGGCCTGGGAATCTGCGCAGGAC 3’  and 5’ GCGGCCGCAATATTTCTA-
ACTGGGCTGC 3’. The amplified were cloned into TOPO vector (Zero Blunt® TOPO® 
Invitrogen) and the vectors were used for bacterial transformation. Each fragment 
was then isolated from bacterial clones and cut out by restriction enzymes reac-
tions. Left arm was cut with ClaI and EcoRV, middle arm with NdeI and NotI and 
the right arm with SnaBI and XhoI. All the fragments were cloned in Psp72 vector 
containing the LoxP-PGK-Puro-LoxP fragment. 
 ES cells were transfected with 20 μg of linearized Psp72 vector caring the 
final construct, and cultured in ES cell medium supplemented with puromycin for 
the positive selection.Individual ES cell colonies that were grown in a Puromycin 
selection environment were picked and expanded individually and DNA was iso-
lated from each one of them. The detection of the integrated construct was done 
by PCR using the following primers in the Venus sequence TATAGACAAACGCACAC-
CGGC (RV) and in the Gata2 genomic sequence CAGCTTCAGCCTGCTTACTCA (FRW). 
The expected length of the amplified fragment was 2292 kb. 
 The Southern probe used for the verification of the correct integration was 
a 382 bp fragment located upstream of the left homology arm The fragment was 
amplified using PhusionTM taq polymerase (Finnzymes F-530L) and the primers used 
were 5’ CTGAAGGATT CCCAGAGCCC A 3’and 5’ AGCAAGAGGCAGGACTGAGTC 3’.
ES cell and EB culturing
 ES cells were cultured on a monolayer of irradiated mouse embryonic fibro-
blast (MEF) feeder cells in ES cell culture medium (DMEM, FBS 15%, Glutamax 1%, 
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Non-Essential Amino Acids 1%, sodium pyruvate 1%, PS 1%, 50μM β mercaptoetha-
nol) with 1000U/ml LIF (Leukemia Inhibitor Factor) at 37oC and 5% CO2. ES cells 
were split 2-3 times per week.
 EB formation was performed as described by Keller (Keller, Webb et al. 
2002). ES cell cultures were harvested and single ES were seeded in suspension in 
ES cell culture medium in the absence of LIF at 37oC and 5% CO2.  ES cell cultures 
were left to differentiate into EBs on a shaker with a slow shaking motion of 50 
rpm for the desired number of days. For d6-d8 EBs the medium was refreshed at 
d3-d4. EBs were made into single cell suspensions by trypsinization. Pelleted EBs 
were incubated at 37oC for 3-5 min. Trypsin was deactivated by addition of 1ml 
IMDM (50%FCS). The EBs dissociation was perfomed by passing the cells through a 
20-gauge needle twice.
Recombination of selection cassette and selection of recombined clones
 The excision of the selection cassette was performed by culturing targeted 
ES cells with diffusible HTN-Cre protein in the culturing medium. HTN-Cre produc-
tion and Cre protein transduction of ES cells were performed as described by Peitz 
et al. (2007). Briefly, single cell suspensions of ES cells were plated, transduced 6 
hours later and cultured in normal ES cell medium containing diluted HTN-Cre glyc-
erol stock at a concentration of 5μM. The ES cells were incubated with the HTN-Cre 
protein for 18h, washed with PBS and cultured until single ES colonies could be 
picked and expanded . 55-60 colonies were picked and expanded, and DNA was iso-
lated from each one of them. A PCR reaction designed to detect the presence of one 
LoxP site in the Gata2 genomic locus was performed to detect recombined clones. 2 
recombined clones were detected G2V5 and G2V6. The primers used were: (FRW) 
GACTTAGAGGTCCTCAGCCT (RV) TAGAGCACAGGCTGCAGCTC. The expected length 
of the wt product is 244 bp and of the recombined one 278 bp.
qRT-PCR
 The sequences of the primers used for the qRT-PCR are presented here: 
ATCTTCTTCAAGGACGACGG Venus Forward (FRW) primer, GGCTGTTGTAGTTG-
TACTCC Venus Reverse (RV) primer, CACCCCTAAGCAGAGAAGCAA Gata2 FRW, TG-
GCACCACAGTTGACACACT Gata2 RV, β-actin. The PCR programme of the reaction 
was: 95oC 3’ min, followed by 40 cycles of 95oC 10’’ sec, 60oC 30’’ sec, 72oC 30’’ sec. 
Protein extraction and Western blotting
 Venus positive and Venus negative sorted cell suspensions were washed 
two times with Phosphate- buffered saline(PBS) and pelleted cells were dissolved 
in RIPA buffer  and incubated for 20’-30’ on ice. Samples were centrifuged at 16000 
g for 15’min and the supernatant was collected and snap frozen in liquid nitrogen. 
The samples were stored in -80oC. For western blotting the equivalent of the same 
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number of cells for each sample was boiled (95oC for 5’min) in SDS sample buffer. 
Samples were loaded on SDS-polyacrylamide gel, electrophoresed and then blot-
ted for 1h 100 volts – 240 mA on a nitrocellulose membrane. The membrane was 
blocked with 1% BSA immunostained with anti Gata2 (Santa Cruz, sc9008x), anti 
GFP (MBL 598) and anti nucleophosmin 1 (Npm1) (B23 (FC-8791) SC-32236) anti-
bodies. The staining was done in TBS buffer and the membrane was washed in TBS-
T. Secondary antibodies used were IRDye 800CW Goat Anti mouse (LI-926-32210) 
and Goat Anti rabbit (LI-926-32211) were used and membranes were analyzed by 
using the Odyssey Infrared Imaging system (Li-Cor Biosciences)
Flow cytometric cell sorting and analysis
 For analyzing cell surface markers expression of EBs cells, EBs were dissoci-
ated (as described before) and made into single cell suspensions and stained with 
PE anti-Flk1 (555308 BD Pharmigen), PE anti-CD31 (5553371 BD Pharmigen), PE an-
ti-c-Kit (5553355 BD Pharmigen), PE anti-CD45 (553081 BD Pharmigen). Dead cells 
were excluded by Hoechst33258 (Invitrogen) staining and analyzed or sorted on a 
FACS aria II SORP. Results analysis was performed by FlowJo software (Tree star).
Matrigel differentiation assay
 96 well dishes were coated with 50 μl of MatrigelTM Basement Mambrane 
Matrix (BD Biosciences cat no 354234). The thin gel method was used to coat the 
plates as described by the manufacturer. Plates were kept at 37oC until use. All oth-
er materials were pre-cooled materials and kept on ice. Cell populations to be used 
in the matrigel differentiation assay were pre-plated in a high glucose containing 
medium (DMEM, 20% FCS, 1% PS) on gelatin coated dishes. After 1-2 days, the cells 
were trypsinized, harvested, suspended in EGM-2 medium (EGM-2 Bulletkit, Lonza, 
cat num CC-3162) and plated on the matrigel coated wells. Plates were incubated at 
37oC and 5% CO2. Tubule and junction formation was observed under a IX70 Olym-
pus fluorescent inverted microscope every 2-3 hours.
Methylcellulose hematopoietic progenitor assay
 Cells were plated in methylcellulose (stem cell technologies) at a concentra-
tion of 2x104 cells/ml. In most cases triplicate plating (300 ul) was performed. After 
10-12 days of incubation at 37oC, CO2 the number of progenitor colonies was scored 
by microscopic observation.
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The dynamics of Gata2 expression actively affect hematopoietic development
Polynikis Kaimakis, Emma de Pater, Undine Hill, Reinier van der Linden, Jean Charles 
Boisset, Catherine Robin, Tomomasa Yokomizo, Elaine Dzierzak
Abstract
 The Gata2 transcription factor is one of the master regulators of hemato-
poietic stem cell (HSC) generation in the mouse embryo. Gata2 germline deletion 
leads to embryonic lethality, severe anemia and an absence of HSCs. Localization 
studies show that it is expressed in some cells in the embryonic hematopoietic sites 
during the different waves of hematopoietic cell generation. ES cell differentiation 
studies and overexpression studies in cell lines implicate a role for Gata2 in the 
expansion, differentiation and/or self-renewal ability of hematopoietic progenitors. 
However, the precise role of Gata2 in the development of HSCs is not fully under-
stood. Previous studies have shown that cell populations sorted for hematopoietic 
markers such as c-kit and Sca-1 express Gata2, but prospective specific isolation of 
viable Gata2 expressing cells for examination of their functional attributes has not 
been feasible. 
 In this study we describe the generation of a Gata2-Venus reporter mouse 
model which allows us to directly isolate, characterize and test the in vivo and in 
vitro functional potential of Gata2 expressing cells. We show that Gata2 expressing 
cell fractions in the aorta, vitelline and umbilical arteries and fetal liver are highly 
enriched in hematopoietic progenitors, and identify a novel subset of progenitors 
that are Gata2 independent. Importantly, we show that all the HSCs are Gata2 ex-
pressing. Live imaging studies demonstrate real-time Gata2 expression in intraaor-
tic cluster cells and aortic endothelial cells at midgestation. These results highlight 
for the first time the dynamic expression of Gata2 in HSC development and suggest 
that changing levels in single cells may influence functional output.
Introduction
 Hematopoiesis is the process by which blood cells are generated. During 
mouse embryonic development several distinct waves of hematopoiesis have been 
described. The first one is characterized by the generation of the blood islands in 
the yolk sac (YS). These are primitive erythroid cells originating from a cell with both 
hematopoietic and endothelial potential, the hemangioblast [review by (Dzierzak 
and Speck 2008)]. In the second wave erythro-myeloid hematopoietic progenitors 
arise (Palis, Robertson et al. 1999). Later on, at E9, cells with lymphoid potential can 
also be detected (Godin, Dieterlen-Lievre et al. 1995; Cumano, Dieterlen-Lievre et 
al. 1996). Finally, in the third wave, the hematopoietic stem cells (HSCs) are gener-
ated at midgestation (E10.5) in the mouse embryo. These are the cells with the 
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potential to differentiate into all the distinct cell types of the blood during the whole 
life span of an individual.  They are characterized by their unique ability to self re-
new. In the adult they reside in the bone marrow (BM) and their development is 
under current intense investigation.
 In the mouse embryo it has been demonstrated that the first HSCs are 
autonomously generated in the aorta gonad mesonephros (AGM) region at E10.5 
(Muller, Medvinsky et al. 1994; Medvinsky and Dzierzak 1996). Apart from the 
AGM, other embryonic tissues have been shown to contain cells with HSC activity. 
These are the vitelline and umbilical arteries (VA and UA) beginning at E10.5 (de 
Bruijn, Speck et al. 2000), the yolk sac (YS) at E11 (Muller, Medvinsky et al. 1994; 
Medvinsky and Dzierzak 1996; Kumaravelu, Hook et al. 2002), the placenta (PL) at 
E11 (Gekas, Dieterlen-Lievre et al. 2005; Ottersbach and Dzierzak 2005) and the fe-
tal liver (FL) where the HSCs migrate and expand at E11 - E11.5 (Muller, Medvinsky 
et al. 1994; Medvinsky and Dzierzak 1996; Kumaravelu, Hook et al. 2002; Gekas, 
Dieterlen-Lievre et al. 2005). The study and understanding of the processes govern-
ing the generation of the HSCs are of major importance for regenerative medicine.
 Cell intrinsic regulation of HSC generation is provided mainly by transcrip-
tion factors which play an important role in directing the hematopoietic gene ex-
pression program. Some of the major transcriptional regulators in HSC generation 
are Gata2, SCL and Runx1 (review by (Dzierzak and Speck 2008; Wilson, Calero-Nie-
to et al. 2011)). Recently it has been shown that these transcription factors work in 
a combinatorial manner by forming transcription factor complexes (Wilson, Foster 
et al. 2010).
 Gata2 is one of the major regulators of HSC generation. Germline deficiency 
for Gata2 results in embryonic lethality between E10-E10.5 and an anemic pheno-
type, with decreased number of primitive hematopoietic progenitors and a mas-
sive decrease in the number of definitive hematopoietic progenitors (Tsai, Keller et 
al. 1994). Profound effects of Gata2 deficiency are also detected in chimeras with 
Gata2-/- ES cells, where no contribution to the hematopoietic tissues by deficient 
cells was found. Further studies on hematopoietic differentiation of Gata2-/- ES cells 
imply that this transcription factor plays a role in the survival or proliferation of the 
multipotent hematopoietic progenitor cells (Tsai and Orkin 1997). The embryonic 
lethality of Gata2-/- embryos at E10.5 precludes the study of AGM HSC generation. 
Instead, studies in Gata2+/- embryos show a greatly reduced number of phenotypic 
and functional HSCs in the AGM region, suggesting an important role for Gata2 in 
HSC generation (Ling, Ottersbach et al. 2004). In situ hybridization studies show that 
Gata2 is expressed in the hematopoietic tissues during all the waves of embryonic 
development. More specifically, Gata2 can be found in endothelial cells and in the 
intraaortic hematopoietic cluster cells. It is also highly expressed in the PL and FL 
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(Nardelli, Thiesson et al. 1999; Minegishi, Suzuki et al. 2003; Robert-Moreno, Es-
pinosa et al. 2005; Pimanda, Ottersbach et al. 2007). High levels of Gata2 mRNA 
expression can be detected in cell populations enriched in HSCs (Orlic, Anderson 
et al. 1995). Overexpression studies and studies in haploinsufficient animals reveal 
that quantitative levels of Gata2 expression play an important role in its function. 
(Heyworth, Gale et al. 1999; Persons, Allay et al. 1999).
 To date, the analysis of specifically enriched Gata2 expressing cells has 
been limited to a reporter mouse model that results in Gata2 haploinsufficiency 
state (Minegishi, Suzuki et al. 2003). In this study we generate and characterize a 
new Gata2-Venus mouse model in which the Venus fluorochrome gene expressed 
in tandem with Gata2 does not affect the normal level or function of Gata2. In the 
embryo, we show that Venus expression recapitulates Gata2 expression and that 
hematopoietic progenitors are enriched in the Venus positive sorted AGM fraction. 
Interestingly, a Gata2 independent hematopoietic progenitor population is identi-
fied in the Venus negative AGM fraction and verified in Gata2-/- embryos. The HSC 
population on the other hand is exclusively Gata2 Venus expressing. Using in vivo 
live imaging we show that Gata2 expression in the aorta is dynamic during the peri-
od of the onset of HSC generation, thus suggesting that the active onset and chang-
ing levels of expression of Gata2 drives hematopoietic development.
Results
Generation and characterization of Gata2-Venus mice
 To directly isolate and examine the potential of Gata2 expressing cells a 
knockin reporter mouse model was generated. Briefly, the coding sequence of the 
Venus fluorochrome gene following an internal ribosome entry site (IRES) sequence 
was recombined into the 3’UTR of the Gata2 genomic locus (fig 1A) in ES cells. A 
puromycin cassette flanked by lox recombination sites was included in the targeting 
construct for selection purposes. The G2V construct and recombination strategy are 
described in detail in chapter 2. This approach allows for the normal expression of 
Gata2 from the regulatory elements within its genomic locus without affecting the 
levels of expression or protein function. These characteristics are particularly im-
portant since Gata2 haploinsufficiency greatly reduces the number of HSCs gener-
ated during development (Ling, Ottersbach et al. 2004).  After blastocyst injections 
and identification of germline transmitting founders, the first generation offspring 
carrying the G2V knockin were crossed with CAG-Cre transgenic mice to excise the 
puromycin selection cassette. Offspring were backcrossed onto the C57BL/6 back-
ground. A  Gata2Venus/Venus mouse colony was established. These mice breed nor-
mally and show no growth defects. They also show no hematopoietic defects since
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they have the same lineage subset distribution with wild type (WT) animals (supple-
mentary table 1), indicating that Gata2 function is normal.
 To determine whether Venus expression parallels that of Gata2 in hemato-
poietic cells, bone marrow was isolated from adult Gata2Venus/Venus mice. Cells were 
flow cytometrically sorted into Venus positive and negative fractions (figure 1B) 
and RNA was isolated. qRT-PCR was performed for Gata2 and Venus sequences. As 
Figure 1 Gata2-Venus model can be used for the prospective isolation of Gata2 
expressing cells
 (A) The targeting strategy for the generation of the Gata2-Venus mouse model is 
presented. In the upper panel Gata2 genomic locus is depicted. Exons are indicated by or-
ange boxes and the position of the STOP codon is shown. In the middle panel the targeting 
construct is depicted with the IRES-Venus coding sequence and the puromycin selection 
cassette coding sequence are indicated by rectangular boxes. The LoxP sites are indicated by 
triangles and the homology regions highlighted. In the bottom panel the predicted structure 
of the targeted allele is shown after the excision of the selection cassette. (B) FACS analysis 
of adult BM. Percentage of Venus expression is indicated in the Venus gate. (C) Relative 
mRNA expression of Venus and Gata2 in Venus positive sorted and Venus negative sorted 
cell populations of adult BM samples. Both Venus and Gata2 can only be found in the Venus 
positive sorted cell fraction.
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shown in figure 1C, only sorted Venus positive cells express Venus and Gata2 mRNA. 
These results indicate that Venus expression from the targeted allele correctly re-
flects Gata2 expression and that our Gata2-Venus mouse model is suitable for the 
isolation and study of Gata2-expressing cells.
Gata2-Venus is expressed in the midgestation aorta and other embryonic hema-
topoietic tissues
 We next examined whether the Venus expression pattern in Gata2-Venus 
embryos is similar to that described by Gata2 in situ hybridization studies (Nardelli, 
Thiesson et al. 1999; Robert-Moreno, Espinosa et al. 2005; Pimanda, Ottersbach 
et al. 2007). Whole mount embryo immunostainings at E10.5 revealed high level 
Venus expression in the AGM and FL, the olfactory bulb (OB) and along the length 
of the neural tube (NT) (fig 2A,B,C). These findings correspond to the previously 
described in situ pattern of Gata2 in these tissues (Nardelli, Thiesson et al. 1999). 
Confocal imaging of thick transverse sections of E10 Gata2-Venus embryos show 
that Venus is expressed in the aorta in the endothelial cell lining of the aorta and in 
intraaortic cluster cells (fig 2D,E). Venus expression is also found in the urogenital 
region of the AGM (fig 2D).  A more detailed analysis of Venus expression in the 
major vasculature of the embryo - the aorta, VA and UA - and other hematopoi-
etic tissues was performed by immunostaining.  Transverse sections of Gata2-Venus 
embryos at different embryonic timepoints E9.5, E10.5 and E11.5) (fig 2E-I) were 
stained with anti-CD31 antibody to detect endothelial and intraaortic hematopoi-
etic cluster cells. Confocal imaging revealed that Venus is expressed in the endothe-
lial cells of the dorsal aorta and the VA/UA at E 9.5 (fig 2E,F) and similarly at E10.5 
and E11.5 (fig 2G,H). At E10.5 high Venus expression in the hematopoietic cluster 
cells is observed (fig 2H).  Apart from the aorta, Venus expression is found in other 
embryonic hematopoietic sites such as the FL (fig 2I), yolk sac and placenta (not 
shown). In the FL, the punctuate pattern of Venus expressing cells is similar to what 
has been previously documented for Gata2 in situ analysis (Pimanda, Ottersbach 
et al. 2007). Thus, Venus expression in Gata2-Venus embryos recapitulates normal 
Gata2 expression.
Gata2 expression levels are dynamic in the midgestation aortic endothelium and 
clusters
 Previous studies have used the Ly6A GFP embryo model (which marks 
HSCs) (de Bruijn, Ma et al. 2002) to track the generation of hematopoietic cells in 
real-time (Boisset, van Cappellen et al. 2010). To track the onset of Gata2 expres-
sion and its relationship to the endothelial to hematopoietic cell transition we per-
formed real-time imaging on thick sections of Gata2Venus/Venus embryos. Live imaging 
of Gata2-Venus embryo sections show that at E10.5 Gata2 is expressed in the aorta 
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Figure 2 Venus expression in hematopoietic tissues during mouse embryogenesis
 (A-C) Confocal imaging of E10.5 whole mount Gata2-Venus embryos immunos-
tained with CD31. Venus expression can be detected in the hematopoietic sites of the aorta 
(indicated in C with a dotted line) and the FL and in the olfactory bulb (indicated in C with 
the initials OB) and alongside the neural tube (indicated in C with the initials NT). (D) Confo-
cal imaging of thick transverse Gata2-Venus embryo sections of E10 embryos. Brightfield 
merged with fluorescent image is shown. The tissues are imaged fresh and Venus fluoro-
chrome expression without any staining is detected. The ventral side of the embryo is po-
sitioned at the bottom of the image. DA stands for Dorsal Aorta and UG for UoroGenital re-
gions. (F-J) Fluorescent microscopic images of transverse sections of E9 (F), E10 (H) and E11 
aortas (I), E9 VA/UA (G) and E11 FL (J). Venus expression co-localizes with CD31 expression 
in cells of the aortic endothelium and in the endothelium of the VA and UA and is expressed 
in a characteristic punctuate pattern in the FL. The arrowheads in 2E,2G,2H indicate a Venus 
expressing endothelial cell. The asterisk in 2G indicates a hematopoietic cluster.
in a very dynamic manner. During 12 hours, we observe emergence of Gata2 ex-
pressing aortic hematopoietic cells and the active movement of hematopoietic clus-
ter cells (video 1 and fig 3). Both the onset and extinction of Venus expression can 
be observed, revealing the highly active regulation of Gata2 transcription in single 
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hematopoietic and/or endothelial cells. The differential expression, as well as the 
fluctuation/oscillation of Venus expression in single hematopoietic cluster/endo-
thelial cells in this small window of time, suggests that the dynamic regulation of 
Gata2 levels is important in the function of the individual cells.
Figure 3 Gata2 expression during E10 AGMs is very dynamic
 Time lapse imaging of E10 Gata2-Venus embryo slices. X20 lens with the ventral 
side in the bottom. Three dimensional image stacks of a thick section of the dorsal aorta are 
shown for different timepoints during a 12 hour confocal imaging session. In all of the sec-
tions the ventral side of the dorsal aorta is in the bottom of the image. Each of the images 
has a two hours time difference. Box on the right indicates the presence of a cell turning on 
Venus expression (at 4h 15min) and box on the left indicates a cell which turns off Venus 
expression (at 10h 15 min) during 10-12h of imaging. Massive morphological changes and 
cell movements in the intraaortic cell cluster are observed. The intraaortic cluster is located 
in the area between the two boxes. In addition, many cell movements in the endothelial cell 
layer can be observed in the video.
Gata2 expressing cells increase in number during development in hematopoietic 
tissues
 To study the role of Gata2 directly in the cells that express it during em-
bryonic stages, flow cytometric analysis was performed at different time points on 
Gata2-Venus hematopoietic tissues (fig 4A). At E9 Venus expression is most promi-
nent in the YS, with 5.8% ±0.6 of viable cells expressing Venus and in the AGM, 1.7% 
±0.1 of cells are Venus expressing. At E10 - E10.5, the time when the first HSCs are 
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generated and the number of intraaortic hematopoietic clusters reaches a maxi-
mum, 1.8% ±0.3 of AGM cells are Venus positive and at E11.5 it increases to 6% 
±0.3. In the FL, the percentages of Gata2-Venus expressing cells increase 100-fold 
from E10 to E11.5, with 0.13% ±0.09 and 12.3% ±0.1 Venus+ cells at these respec-
tive time points. The total number of Gata2-expressing cells in these tissues is 
shown in table 1 and fig 4B.
Table 1 Number of Venus+ cells / embryonic tissue
 Absolute number of Venus positive cells in each embryo equivalent (ee) is present-
ed. Dissected embryonic tissues (YS, AGM, FL) were made into single cell suspensions and 
FACS analysis was performed to define the percentage of cells expressing Venus. For E10.5, 
the AGM tissue (186x103 cells/ee) was used but for E11.5 AGM, we included the embryo 
body part of the VA and UA (270x103cells/ee).  Our data for the total number of cells in each 
tissue correlated with published data for YS and E9.5 AGM (Dzierzak and de Bruijn 2002) and 
for FL (Gekas, Dieterlen-Lievre et al. 2005).
 Staining of Gata2-Venus embryo hematopoietic tissues with c-Kit and CD31 
antibodies can provide a more in depth analysis of the Gata2 expressing cell popula-
tion. The triple positive (CD31hic-Kit+Venus+) cell fraction represents hematopoietic 
cells present at the intraaortic clusters. At E10.5 the absolute number of these triple 
positive cells in one embryo equivalent (ee) is 373 and at E11.5 this number drops 
to 175 (table 1). This reduction is comparable to the reduction of hematopoietic 
intraaortic clusters and cells that has been previously reported (Yokomizo and Dzi-
erzak 2010) from E10.5 to E11.5. At the same time points the CD31intc-Kit-Venus+ cell 
fraction represents endothelial cells expressing Gata2. It has already been show by 
the immunostainings that endothelial cells express Gata2. Part of this cell fraction 
might represent hemogenic endothelial cells that have not yet acquired hemato-
poietic fate. The remainder of the Venus+ cells are likely to be in the gonads region 
of the AGM (fig 2D). The absolute number of Gata2-Venus expressing cells in the 
hematopoietic tissues at E9.5, E10.5 and E11.5 is presented in detail in table 1.
Table 1
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 Gata2 expression in the major embryonic vasculature defines most hema-
topoietic progenitors and reveals a Gata2 independent subset
 To test the hematopoietic function of Gata2 expressing cells, AGM cells 
were sorted into Venus positive and negative fractions and plated in the methylcel-
lulose progenitor assay. High enrichment of hematopoietic progenitors was found 
in the Venus positive cell fraction. At E9 the Venus expressing cell fraction yielded 
51.61 ±9.58 colony forming units (CFU) per embryo, 2.2-fold more than in the Venus 
negative fraction (22.95 ±3.40 ) (fig 5A). At E10, CFU numbers increased: 3.5-fold 
more CFU were found in the Gata2 expressing AGM cell fraction (93.03 ±15.42) 
as compared to the Gata2 negative fraction (26.36 ±11.3) (fig 5B). Similarly at E11 
there were 3.8-fold more CFU in the Venus positive fraction as compared to the Ve-
nus negative fraction (167.30 ±29.94 and 43.65 ±7.79 respectively: fig 5C). Total CFU 
numbers in both sorted fractions increased with developmental time and all types 
of progenitors (uni, bi and multipotential) were found. Most notably, multipotent 
progenitors forming mixed colonies of granulocyte, erythroid, megakaryocyte, mac-
rophage cells (CFU-GEMM) were found almost exclusively in the Venus expressing 
cell fraction. The Venus expressing fraction at E9, E10 and E11 showed 7.9-, 8.1- and 
21.4- fold more CFU-GEMM than the Venus negative fraction. Detailed results of 
methylcellulose progenitor assays are shown in table 2. These data clearly demon-
strate that the Gata2 expressing cell fraction is highly enriched in hematopoietic 
progenitors, especially the most immature multipotential progenitors.
 Surprisingly a significant number of non-Gata2 expressing hematopoietic 
progenitors were found. These progenitors may have once expressed Gata2 and 
then extinguished its expression. Alternatively, a Gata2 independent progenitor 
subset may exist. To test this we performed methylcellulose assays on AGM cells 
Figure 4 Gata2 is expressed in all the hematopoietic sites during mouse embryonic 
development
 (A) Representative FACS plots demonstrating % of cells expressing Venus in: E9 YS, 
E9 AGM, E10 AGM, E11 AGM and E11 FL. Gates indicate the Venus positive cell fraction. 
Same gatings were used for the sorting of the cell populations in functional experiments. 
FACS analysis of Gata2-Venus E11.5 AGM stained against CD31 and c-Kit. In the plot the 
gated CD31 positive cell population is shown for Venus and c-Kit expression. 4.16% of CD31+ 
are c-Kit+ Venus+ positive hematopoietic cluster cells. The C31+ c-Kit- Venus+ cell fraction 
represents endothelial cells and the C31+ c-Kit+ Venus- cell fraction possibly represents 
Gata2 independent hematopoietic progenitors. (B) Absolute numbers of Venus positive cells 
in individual embryonic tissues (ee=embryo equivalent). (C) Absolute number of triple posi-
tive cell population (CD31hic-Kit+Venus+) at E10.5 and E11.5 embryos. This cell population 
represents hematopoietic cells of the intraaortic clusters. The reduction of hematopoietic 
intraaortic cluster cells between E10.5 and E11.5 has already been reported in the literature 
(Yokomizo and Dzierzak 2010).
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Table 2 Hematopoietic progenitor numbers from Venus positive and Venus nega-
tive sorted cells of E9, E10 and E11 AGMs 
 AGM tissues were dissected and single cell suspensions were sorted based on Ve-
nus expression. The two different cell populations were plated on methylcellulose progeni-
tor assays. 1 or 0.3 embryo equivalents were plated in one plate or in triplicate regarding 
the number of expected progenitors in each tissue. Number of colonies was scored 12 days 
after culture. E9 embryos: 24-29 sp (n=2). E10 embryos: 30-35 sp (n=2). E11 embryos: 45-48 
sp (n=2). Bar graphs representative of these data are shown in fig 5 A, B and C.Gata2-/- em-
bryos.
from Gata2-/- embryos. Early E9 Gata2-/- AGMs contained 16.7 ±5.7 CFU, an almost 
identical number of CFUs as found in the Venus negative fraction of Gata2-Venus 
E9 AGMs (comparison between fig 5A and 5D, and tables 2 and 3). Whereas most 
colony types were found, few Gata2-/- CFU-GM and no CFU-GEMM were observed. 
Thus, Gata2 independent progenitors exist and for the first time this distinct subset 
of cells can be isolated from progenitors that express and require Gata2. 
 Further evidence concerning the existence of hematopoietic progenitors in 
the Gata2-/- embryos comes from whole mount immunostaining with the hemato-
poietic marker c-Kit. c-Kit+ hematopoietic cells can be observed in Gata2-/- embryos 
in VA and UA. These clusters are reduced in size and number as compared to  WT 
and Gata2+/- embryo (fig 5E and F). 
Further hematopoietic progenitor enrichment and subset discrimination in the 
Gata2-Venus:Ly6A-GFP double reporter mouse model
 Mouse models similar to our Gata2-Venus have been used as a means of 
defining cell populations enriched in HSC activity. Studies with the Ly6A-GFP re-
porter mouse model (de Bruijn, Ma et al. 2002; Ma, Robin et al. 2002) have been 
particularly informative concerning HSC generation. Interestingly, the Ly6A-GFP and
Table 2
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Figure 5 Gata2 expressing cell fraction defines most hematopoietic progenitors
 (A-C) Methylcellulose progenitor assays of (A) E9, (B) E10 and (C) E11 AGMs of 
Venus positive and Venus negative cell fractions. In the graphs the total number of progeni-
tors in 1 ee of Venus positive and the Venus negative sorted cell fractions are presented. 
Single cell suspensions of E9, E10 and E11 AGMs were sorted based on Venus expression 
and 1-0,3 embryo equivalents of cells were plated in a single dish or in a triplicate of meth-
ylcellulose respectively. The number of colonies was scored after 12 days in culture. (D) 
Wild type (WT), heterozygote (Gata2+/-) and mutant (Gata2-/-) AGMs derived from crossings 
between Gata2+/- mice were tested for the number and type of myeloid progenitors present. 
In the early E10 AGM tissues of WT embryos 62.4 ±20.8 progenitors were found, whereas 
Gata2+/- and Gata2-/- AGMs showed a great reduction in the number of progenitors (27.6 
±10.1 and 16.7 ±5.7 respectively) which represents a 3.7 fold decrease between the WT 
and the Gata2-/- animals (p<0.05). Even greater differences were observed in the number of 
multipotent progenitors (CFU-GEMM, CFU-GM). The number of CFU-GEMMs was 4.7 fold 
decreased in Gata2+/- AGMSs (p<0.05) while completely absent in the Gata2-/- AGMs and the 
number of CFU-GMs was 5.2 fold decreased in Gata2+/- AGMs (decrease not significant) and 
75.4 fold decreased in Gata2-/- AGMs (p<0.1) (table 3). Detailed description of the number 
and different types of colonies of each cell population in the different developmental time 
points is presented in table 2. (E,F) Whole mount immunostaining against c-Kit. Hematopoi-
etic clusters and cells are observed in WT VA/UA (C) and Gata2-/- animals. The size and the 
number of the clusters and the number of the c-Kit+ cells are greatly reduced in the Gata2-
/- embryos.
Gata2-Venus expression patterns in the E10 aortic endothelium and cluster cells 
are very similar. To examine whether the Ly6A-GFP expressing cell population com-
pletely overlaps with the Venus expressing population we crossed our Gata2-Venus 
mice with Ly6A-GFP mice. Double reporter embryos were generated and AGM cells 
were sorted into four distinct populations (fig 6A). A small percentage (1%) of AGM 
cells expresses both markers. The results of methylcellulose assays show that all 
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Table 3 Hematopoietic progenitors number in late E9 - early E10 Gata2+/+, Gata2+/- 
and Gata2-/- AGM and YS
 AGM and YS tissues were dissected from the embryos and single cell suspensions 
were plated on methylcellulose progenitor assays. Three experiments were performed 
(n=3) and the number of wt,+/- and -/-  embryos analyzed was 7, 10 and 9 respectively. 
The numbers of the different types of progenitors present in one embryo equivalent (1ee) 
are presented in the table. CFU-E: erythroid colonies, CFU-G: granulocyte colonies, CFU-M: 
macrophage colonies, CFU-GM: granulocyte, macrophage colonies, CFU-GEMM: granulo-
cyte, erythrocyte, monocyte, megakaryocyte colonies. The differences between the progen-
itor numbers in +/+ and -/- animals are significant (p<0.05 for the total AGM, CFU-GEMM 
AGM, CFU-M AGM, total YS, CFU-GM YS, CFU-M YS, CFU-G YS, CFU-E YS and p<0.1 for CFU-
GM AGM, CFU-G, CFU-E, CFU-GEMM.)
four sorted populations contain hematopietic progenitors. The double positive cell 
population (Venus+GFP+) is the most highly enriched in progenitor activity (53.8 
±22.9 CFU/ee) and it contains the highest proportion of multipotent progenitors, 
CFU-GEMM (fig 6B). Although the single positive and double negative fractions con-
tain more cells, 2-3 times fewer CFU/ee are found. CFU-G appear to be enriched 
in the Venus- fractions, whereas the Venus+ fractions are enriched in CFU-M, sug-
gesting that Gata2 influences lineage fate. Detailed results of the methylcellulose 
progenitor assay are presented in table 4.
All long-term repopulating AGM HSCs are Gata2 Venus expressing and phenotypic 
analysis indicate that they are Gata2 intermediate expressing
 Despite previous data showing that HSC enriched populations transcribe 
Gata2, it has been unclear whether all HSCs express Gata2 and to what level. To 
test this, the Venus positive and negative E11 AGM cell fractions were examined 
for HSC activity by in vivo transplantation assays. The two sorted cell populations 
were injected into irradiated adult animals and engraftment was analyzed at four 
months post transplantation. Long term, high level engraftment (>10%) by Venus+ 
donor cells was found only in the Venus expressing cell population (table 5). No 
engraftment was found in any of the 11 recipient mice injected with up to 8 embryo 
equivalents of Venus- AGM cells. Thus, all adult repopulating HSCs express Gata2. At 
E14 and E16, when the HSCs are located in the FL, flow cytometric analysis for SLAM 
Table 3
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markers strongly indicates that the HSCs are located in the Venusint cell fraction. 
More specifically, at E14 the CD150+CD48- cell population, which includes the HSCs 
(Kim, He et al. 2006), cannot be found in the Venushi cell fraction, while 8% of Ve-
nusint expressing cells is CD150+CD48- (data not shown). At E16, the Venushi only a 
1.45% of Venushi cells express CD150 and only 29.5% of them express c-Kit while in 
the Venusint cell fraction 95.7% of the cells are c-Kit+ and 41.5% are Cd150+, again 
indicating that the HSCs are located in the Venusint cell fraction(data not shown).
Table 4 Ly6A-GFP+:Gata2-Venus+ cell fraction is highly enriched in hematopoietic 
progenitors
 Methylcellulose progenitor assay of the four cell populations isolated from Ly6A-
GFP:Gata2-Venus double positive animals. In the table the number of progenitors present 
in each cell fraction in 1 ee is presented. The double positive cell fraction is highly enriched 
in hematopoietic progenitors and especially in GEMMs.
Figure 6 Venus+GFP+ cell fraction is highly enriched in hematopoietic progenitors
 (A) FACS analysis of E11 AGM of a Ly6A-GFP:Gata2-Venus embryo. The four distinct 
cell populations were sorted and plated on methylcellulose progenitor assays. (B) Number 
of progenitors present in each cell fraction in 1 embryo equivalent of tissue. The double 
positive cell fraction is highly enriched in hematopoietic progenitors and especially in CFU-
GEMM.
Table 4
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Table 5 All of the long term HSCs are found in the Venus+ cell fraction
 HSC activity in Venus positive and Venus negative cell populations of E11 AGMs 
(41-49 sp fluctuation). 2-5 ee of each cell fraction was injected into adult lethally irradiated 
mice. Results of 5 experiments are presented for the long term (4 months) reconstitution 
capacity.  In the table the number of animals showing reconstitution out of the number of 
total injected animals after 4 months. The reconstitution efficiency was tested by PCR de-
signed to detect the Venus allele in DNA isolated by peripheral blood.
Table 5
Discussion
 In this study we describe the generation of a new Gata2-Venus reporter 
mouse model in which Venus fluorochrome is used as a marker of the Gata2 ex-
pressing cells. For the first time it is possible to show that all HSCs in the developing 
mouse embryo express Gata2. Moreover, we show that most but not all hemato-
poietic progenitors are Gata2 dependent. We followed a strategy in which Venus 
coding sequence is recombined into the 3’UTR of Gata2 genomic locus. This strat-
egy minimizes the possibility of altering in the expression levels and function of the 
Gata2 transcription factor. A similar strategy has previously been followed for the 
generation of a PU.1 transcription factor fluorescent reporter mouse. This mouse 
model (Nutt, Metcalf et al. 2005) revealed that different levels of PU.1 expression 
define distinct progenitor populations and correlates the downregulation of PU.1 
expression with loss of myeloid linege potential and restriction to megakaryocyte 
and erythroid (MegE) lineages.
 Analyses of our reporter model show that Gata2Venus/Venus mice have no pro-
found hematopoietic defects and that they breed normally. We found in sorted 
cell fractions that Venus and Gata2 are only expressed in the Venus positive cells. 
Localization analyses of Venus expression in Gata2Venus/Venus embryos show a simi-
lar expression pattern with published Gata2 in situ hybridization results (Nardelli, 
Thiesson et al. 1999; Robert-Moreno, Espinosa et al. 2005; Pimanda, Ottersbach et 
al. 2007). These data verify that our new Gata2-Venus reporter mouse model is suit-
able for prospective isolation and analysis of Gata2 expressing cells directly from 
the normal in vivo physiologic setting without manipulation.
 Imaging and FACS analyses of Gata2-Venus embryos confirm that Gata2 is 
expressed in all the hematopoietic sites during mouse embryogenesis. Interestingly, 
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the numbers of Gata2 expressing cells change in accordance with developmental 
and temporal hematopoietic changes occurring in these sites. At E9 Venus express-
ing cells are found predominantly in the YS, which at this time produces the high-
est numbers of the hematopoietic progenitors in the conceptus. Slightly later as 
hematopoiesis begins in the AGM and then the FL, the numbers of Gata2 express-
ing cells also increase. At E10.5, the highest numbers of hematopoietic CD31+ckit+ 
cluster cells are found in the aorta, vitelline and umbilical arteries as quantitatively 
shown by whole mount embryo imaging (Yokomizo and Dzierzak 2010). Similarly, 
CD31+c-Kit+Venus+ cell numbers are also highest in the vasculature at E10.5 and 
are decreased at E11.5. These quantitative data indicate that Gata2 is expressed in 
hematopoietic cluster cells but that not all cluster cells express Gata2 perhaps indi-
cating that as Gata2 expression is downregulated hematopoietic cells mature and 
or differentiate in the clusters. Importantly, Gata2 is also expressed in the endothe-
lial cells of the dorsal aorta. Already at E8.5, Gata2 is expressed in the endothelial 
cells lining the paired dorsal aorta and continues to be expressed in the E10.5 aorta 
when HSCs are generated, thus highlighting a possible role for Gata2 in directing the 
hemogenic program of endothelial cells.
 Live imaging of Gata2-Venus embryos shows that Venus expression is highly 
dynamic in the aorta at the time of HSC generation. The turning on and turning off 
of Gata2 expression, as well as the active movements of Gata2 expressing cells 
in intraaortic clusters, suggests that Gata2 may also affect other processes at this 
developmental timepoint. For example, changes in the levels of Gata2 expression 
at the single cell level may influence hematopoietic function. The half life (1/2 life) 
of Gata2 protein still needs to be precisely calculated and compared with that of 
Venus protein. For this sensitive western blotting on the possible maximum number 
of Venus positive sorted cells will be attempted. 
 It is well known that Gata2 haploinsufficiency affects the quantitative ap 
pearance of HSCs in the AGM (Ling, Ottersbach et al. 2004). The dynamic expression 
of Gata2 in the aorta brings to mind recent findings of transcription factor oscilla-
tion in pluripotent stem cells (Glauche, Herberg et al. 2010; Wee, Yio et al. 2012). 
Fluctuations in transcription factor expression levels are thought to influence cell 
fate (Nutt, Metcalf et al. 2005). Further live imaging, the analysis of more cell sur-
face markers (greater enrichment) and functional analyses are necessary to confirm 
a role for Gata2 and levels of Gata2 expression in the transition from hemogenic 
endothelial to a hematopoietic cell fate.
 The advantage of the Gata2-Venus mouse model is in the direct isolation 
of Gata2 expressing cells. The functional characterization of the Venus positive cell 
fraction showed that it is enriched in hematopoietic progenitors and contains all 
long term repopulating HSCs. Interestingly, the Venus negative cell fraction always 
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contained a limited number of hematopoietic progenitors – a Gata2 independent 
subset of hematopoietic progenitors. We showed that the number of hematopoiet-
ic progenitors present in the Venus negative cell fraction of the E9 embryos is com-
parable to progenitor numbers in the Gata2-/- embryos, thus verifying the existence 
of Gata2 independent progenitor subset (fig 5 and tables 2 and 3). These progeni-
tors are restricted in their differentiation potential predominantly to the macro-
phage lineage and may represent the source of primitive macrophages. In addition, 
Gata2-/- embryos show only a few hematopoietic c-kit+ cluster cells in the vitelline 
and umbilical arteries indicating that Gata2 might have an important role in the 
hemogenic endothelial cell compartment before or during the generation/emer-
gence of hematopoietic cells. Gata2 independent progenitors may arise differently, 
perhaps directly from hemangioblasts. It is also possible that Gata2 is required for 
the proliferation and/or maintenance of hemogenic endothelial cells. 
 Finally, a more precise characterization of the Gata2 expressing cell frac-
tion by multiple cell surface markers and combination of this reporter with other 
reporter mouse models will lead to a better understanding of the role Gata2 in the 
development and function of multipotential hematopoietic progenitors and HSCs. 
Preliminary results of immunostaining experiments of Gata2-Venus embryonic cells 
with hematopoietic and endothelial markers have identified a population highly 
enriched in multipotent hematopoietic progenitor activity (data not shown). Com-
bination of Gata2-Venus mice with Ly6A-GFP reporter mice allowed us to identify 
a double positive cell population highly enriched in hematopoietic progenitors and 
especially multipotent progenitors (CFU-GEMM). This double positive cell fraction 
is a promising candidate for being highly enriched in HSC activity. Purification of 
HSCs and their direct precursors, the hemogenic endothelium, together with tran-
scriptome and genetic analyses, will allow for an understanding of the role of Gata2 
in embryonic hematopoiesis and the generation of HSCs.
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Materials and Methods
Mice and embryos
 For the generation of Gata2-Venus mouse model IB10 G2V ES cells (129SV 
background) targeted with Gata2-Venus targeting construct, showing correct con-
struct integration and karyotype, were used for blastocyst injections into C57BL/6 
mice. The produced chimeric mice were crossed again with c57bl6 mice and the 
ones with germline transmition were used for the used for the production of the 
f1 of the Gata2-Venus mice. The positive mice for the Gata2-Venus construct were 
backcrossed with CAG-Cre mice for the excision of the puromycin selection cas-
sette. Correct selection cassette excision was tested by PCR detecting the presence 
of a LoxP site in the Gata2 genomic locus (details in chapter 2). 
 Gata2-/- and Ly6A-GFP mice are kept in a C57BL/6 background.  Timed mat-
ings were performed with Gata2-Venus males and Ly6A-GFP or WT (c57bl6) females 
and Gata2+/- males with Gata2+/- females. The day of the plug detection was scored 
as E0. Mice are housed according to institutional guidelines with free access to food 
and water.
qRT-PCR
 The sequences of the primers used for the qRT-PCR are presented here: 
ATCTTCTTCAAGGACGACGG Venus Forward (FRW) primer, GGCTGTTGTAGTTG-
TACTCC Venus Reverse (RV) primer, CACCCCTAAGCAGAGAAGCAA Gata2 FRW, TG-
GCACCACAGTTGACACACT Gata2 RV, β-actin. The PCR program of the reaction was: 
95oC 3’ min, followed by 40 cycles of 95oC 10’’ sec, 60oC 30’’ sec, 72oC 30’’ sec. The 
relative mRNA expression was normalized according to β-actin expression.
Whole mount- immunostainings
 Preparation and immunostaining of mouse embryos was performed as de-
scribed by (Yokomizo and Dzierzak 2010; Yokomizo, Yamada-Inagawa et al. 2012). 
Rat anti mouse primary antibodies for c-Kit (2B8) and biotinylated anti–CD31 
(MEC13.3) from BD Biosciences. Anti GFP (MBL 598) from MBL. Secondary antibod-
ies used: goat anti-rat IgG antibody-Alexa Flour 647, anti-rabbit IgG antibody Alexa 
Flour 488 from Invitrogen and streptavidin Cy3 (Jackson Immunoresearch).
In vivo live imaging
 E10 embryos were dissected in in phosphate-buffered saline (PBS)/10% fe-
tal calf serum (FCS)/1% penicillin/streptomycin solution. The somite pairs of the 
E10 embryos were ranging between 30-34 somite pairs when the embryos were 
taken out of the uterus. Embryos were dissected, immunostained, cut in to slices, 
imaged by confocal microscope [Leica SP5 AOBS DMI600 inverse microscope (Leica 
Microsystems)] and the collected videos were processed as described by (Boisset, 
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van Cappellen et al. 2010; Boisset, Andrieu-Soler et al. 2011).
Immunohistochemical staining
 Gata2-Venus embryos were fixed in 2% paraformaldehyde/PBS for 30’ in 
room temperature (RT), equilibrated with 20% sucrose overnight at 4oC and quick 
frozen in Tissue Tek. Frozen samples were kept at -80oC. Cryosections of transverse 
sections were treated in 100% acetone for 10’min, washed in PBS, blocked in 5% 
goat serum in PBS, washed (3x 5’min) in PBS and stained with anti-GPF antibody (Rb 
pAb to GFP ab290-50 ab-cam) at RT for 1-2 hours (h), washed in PBS and stained 
with goat anti-rabbit Alexa-488 (Goat a Rabbit IgG Alexa Fluor 488 Invitrogen). Sub-
sequent washing in PBS and staining against CD34-biotinilated (cl RAM34 BD-Bio-
sciences PharMigen) for 1h RT was followed by PBS washing step and streptavidin-
Cy5 (cat#016-170-084 Jackson Immunoresearch), PBS washings and mounting with 
vactashield with DAPI (Vector Labs). The sections were observed either in a confocal 
microscope (Leica SP5 AOBS DMI600 inverse microscope (Leica Microsystems)) or in 
a fluorescent microscope (Zeiss AxioImager Z1 upright microscope).
Confocal microscopy
 Whole mount immunostained embryos were imaged in a confocal micro-
scope [Leica SP5 AOBS DMI600 inverse microscope (Leica Microsystems)]. Lasers 
used: 488-, 561-, 633- nm wavelengths. Images were obtained with 20x objection 
lense, pinhole was set at 1 Airy unit and the z steps were 0.8-2.3  μm as previously 
described by (Yokomizo and Dzierzak 2010; Yokomizo, Yamada-Inagawa et al. 2012).
Cell preparation for flow cytometry
 Embryo tissues from E9, E10 and E11 were dissected in phosphate-buff-
ered saline (PBS)/10% fetal calf serum (FCS)/1% penicillin/streptomycin solution 
and made into single cell suspensions by collagenase (0.125% in PBS/10% FCS/1% 
penicillin/streptomycin) treatment (45’min 37oC). The antibodies used for the FACS 
analysis were CD31 PE (MEC13.3) and c-Kit APC (2B8) both from BD Pharmigen 
for better combination with Venus fluorochrome. Viability selection was performed 
with Hoechst 33258 (Invitrogen) staining. FACS analysis was performed in a FACS 
Aria II SORP and data analyzed by FlowJo (Tri Star).
Methycellulose hematopoietic progenitor assay
 In vitro clonogenic analysis was performed by plating sorted cell popula-
tions in methylcellulose medium (M3434, StemCell Technologies) and incubate in 
37oC, 5% CO2. The number and type of colonies were scored in an inverted micro-
scope 10-12 days after plating.
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SUMMARY
Combinatorial transcription factor (TF) interactions
control cellular phenotypes and, therefore, underpin
stem cell formation, maintenance, and differentia-
tion. Here, we report the genome-wide binding
patterns and combinatorial interactions for ten key
regulators of blood stem/progenitor cells (SCL/
TAL1, LYL1, LMO2, GATA2, RUNX1, MEIS1, PU.1,
ERG, FLI-1, and GFI1B), thus providing the most
comprehensive TF data set for any adult stem/
progenitor cell type to date. Genome-wide computa-
tional analysis of complex binding patterns, followed
by functional validation, revealed the following:
first, a previously unrecognized combinatorial inter-
action between a heptad of TFs (SCL, LYL1, LMO2,
GATA2, RUNX1, ERG, and FLI-1). Second, we impli-
cate direct protein-protein interactions between
four key regulators (RUNX1, GATA2, SCL, and ERG)
in stabilizing complex binding to DNA. Third,
Runx1+/::Gata2+/ compound heterozygous mice
are not viable with severe hematopoietic defects
at midgestation. Taken together, this study demon-
strates the power of genome-wide analysis in gener-
ating novel functional insights into the transcriptional
control of stem and progenitor cells.
INTRODUCTION
Combinatorial interactions of transcription factors are key deter-
minants of tissue identity. Early recognition of this came from
overexpression experiments where, for example, the myogenic
family of transcription factors (TF) could induce muscle pheno-
type in non-muscle cells (Davis et al., 1987) or combinations of
hematopoietic TFs reprogram nonhemogenic mesoderm into
blood during development (Gering et al., 2003). The particular
power of combinatorial TF interactions has been highlighted
more recently by the derivation of induced pluripotent cells
through expression of pluripotency-associated TFs in differenti-
ated cells (Takahashi and Yamanaka, 2006), as well as the trans-
differentiation of pancreatic exocrine cells into insulin-secreting
b-cells (Zhou et al., 2008) and the direct conversion of fibroblasts
to functional neurons (Vierbuchen et al., 2010) following exoge-
nous expression of specific trios of transcriptional regulators.
The requirement for specific TF combinations is likely to reflect
combinatorial interactions of those TFs when binding to regula-
tory elements of their target genes. In line with this hypothesis, it
has been shown that the pluripotency factors OCT4, SOX2, and
NANOG co-occupy regulatory elements of many gene loci in
embryonic stemcells (ESCs) (Boyer et al., 2005). Systematic anal-
ysis of combinatorial transcriptional control mechanisms will
require genome-wide information on combinatorial transcription
factor binding. Significant progress in this regard has been
made to further our understanding of ESCs, where genome-
wide occupancy patterns have been established for more than
a dozen TFs (Chen et al., 2008). Recent sophisticated computa-
tional analysis of these comprehensive data sets is beginning to
reveal mechanistic insights into the transcriptional programs
operating in ESCs (Gao et al., 2009). However, with the exception
of ESCs, no comprehensive TF binding data sets have been
reported for any other mammalian stem/progenitor cell types.
Hematopoiesis has long served as a model system for
studying transcriptional control of cell-fate choice and subse-
quent differentiation. Single or pairs of transcription factors can
specify differentiation of progenitor cells into distinct mature line-
ages (Laslo et al., 2006; McNagny et al., 1998; Nerlov and Graf,
1998; Nerlov et al., 1998; Spooner et al., 2009; Ye and Graf,
2007), and detailed functional analysis of individual regulatory
elements controlled by these factors has led to the identification
of specific regulatory codes such as the Gata/E-box motif in red
blood cells or the Ets/Ets/Gata motif in stem and progenitor cells
(Donaldson et al., 2005; Pimanda et al., 2007b; Wadman et al.,
1997). However, because identification of these regulatory
codes was largely based on detailed functional studies of
specific regulatory elements, it is not clear how widely relevant
they are across the whole genome nor how they would interface
with other transcription factor complexes.
The advent of ChIP-Seq technology coupling chromatin
immunoprecipitation with high-throughput sequencing has
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made the generation of genome-wide maps of transcription
factor binding a realistic undertaking. Especially when coupled
with extensive validation and sophisticated bioinformatic
analysis, these new approaches can provide novel hypotheses
on transcriptional control mechanisms. For example, our recent
ChIP-Seq analysis of the SCL/TAL1 transcription factor in the
multipotent hematopoietic progenitor cell line 7 (HPC-7) followed
by extensive validation in transgenic mice established a suitable
model system for global analysis of transcriptional programs in
early progenitor cells by providing in vivo validated links between
SCL and 15 other hematopoietic TFs. Similarly, a recent analysis
of a model cell line for terminal erythroid differentiation provided
a genome-wide view of SCL interplay with the transcriptional
regulators LDB1, GATA1, and ETO2/MTGR1 in a mature hema-
topoietic lineage (Soler et al., 2010).
Here, we report genome-wide binding profiles for ten key
hematopoietic transcriptional regulators (SCL/TAL1, LYL1,
LMO2, GATA2, RUNX1, MEIS1, PU.1, ERG, FLI-1, and GFI1B)
in hematopoietic progenitor cells. Integrated analysis of these
data sets provides a comprehensive genome-wide view of
combinatorial interactions between these ten key regulators. In
particular, multiple independent lines of evidence demonstrate
close collaboration between seven hematopoietic stem/progen-
itor cell (HSPC)-associated TFs, including functional links
between RUNX1 and other key HSPC regulators. Subsequent
in vitro and in vivo validation confirmed a previously unrecog-
nized synergism between the three central regulators of blood
stem cell development, SCL, GATA2, and RUNX1, thus demon-
strating how comprehensive analysis of genome-wide data sets
can provide novel insights into transcriptional control of stem/
progenitor cells.
RESULTS
Key Hematopoietic Transcription Factors Differ
in the Number of Their Genomic Targets
We recently reported genomic targets of the SCL transcription
factor in the multipotential model hematopoietic progenitor cell
line HPC-7 (Wilson et al., 2009). Extensive in vivo validation of
SCL-bound enhancers in transgenic mice validated HPC-7 as
an excellent model system for early hematopoietic stem/progen-
itor cells. However, because of the absence of a negative control
ChIP-Seq data set, we had limited peak identification to those
with the lowest false discovery rate, which resulted in 228 high
confidence peaks. To address this limitation, we have now
generated a new Scl ChIP-Seq data set (15,350,104 uniquely
mappable reads) together with a control IgG ChIP sample
(9,012,777 uniquely mappable reads), which allowed us to
analyze our Scl ChIP-Seq data using software tools specifically
designed to distinguish artifactual peaks found in both test and
control samples from true binding events (see Experimental
Procedures). This resulted in the identification of 7096 statisti-
cally significant peaks (see Experimental Procedures). Impor-
tantly, analysis using the new negative control sample not only
retained all except ten of the original peaks, but also allowed
us to identify more than 6,800 new genomic locations bound
by SCL in hematopoietic cells (Table S1).
We had previously shown that Gata, Ets, Runx, Gfi, and Meis
consensus binding motifs were highly overrepresented in SCL-
bound regions (Wilson et al., 2009), suggesting cooperation
between Scl and other major hematopoietic regulators. To
directly investigate potential combinatorial interactions at
a genome-wide scale, we have now performed ChIP-Seq assays
for an additional nine transcriptional regulators of HSCs that
would be expected to bind to these motifs. LYL1, LMO2, and
GATA2 would be expected to bind to GATA-E-box sites;
RUNX1 to the Runx motifs; MEIS1 to the Meis sites; PU.1,
ERG, and FLI-1 to the Ets sites; and GFI1b to the Gfi consensus
(the latter was chosen because even though both GFI1 and
GFI1b are expressed in HSPC, GFI1b shows higher expression
levels in HPC-7 cells). Peaks of transcription factor binding
were identified using the negative control IgG sample as before
yielding 4350 LYL1, 9604 LMO2, 9234 GATA2, 5258 RUNX1,
8386 MEIS1, 22720 PU.1, 19601 FLI-1, 36137 ERG, and 8853
GFI1B (for peak coordinates, see Table S1). To characterize
the distribution of binding events across genomic features, we
determined the number of peakswithin ± 1 kb from the transcrip-
tion start sites (promoter peaks) and partitioned the remaining
peaks into those within and between genes (intragenic and inter-
genic, respectively; see Figure 1). For LYL1, LMO2, GATA2, and
Figure 1. Key Hematopoietic Transcription Factors Differ in the
Number of Their Genomic Targets
The number of peaks for each transcription factor was determined as outlined
in Experimental Procedures. Each peak was then allocated to be either within
a promoter, intragenic, or intergenic region. The pie chart visually shows the
distribution of the peaks across those three categories (blue, green, and red,
respectively). For lists of peaks bound by 10 TFs and genes associated with
those peaks, see Tables S1 and S2.
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RUNX1, very few peaks were observed over promoter regions,
with the bulk of binding events more or less evenly distributed
between intra- and intergenic sites. SCL, MEIS1, PU.1, ERG,
FLI-1, andGFI1B showed binding to a larger number of promoter
regions, and again, nonpromoter peaks were evenly distributed
between intra- and intergenic regions. To facilitate use of this
very large data set for the wider community, we generated
comprehensive supplemental data, all of which can be
downloaded from our website http://hscl.cimr.cam.ac.uk/
ChIP-Seq_Data/ChIP-Seq.html. These include the following
files: (1) custom track (.wig) files to display ChIP-Seq profiles
for each of the 10 factors in genome browsers; (2) a table listing
the peak positions for all ten TFs (Table S1); and (3) a table listing
all UCSC genes indicating which (if any) of the ten factors bind to
their respective gene loci (within the body of the gene and up to
50 kb 50 and 30 intergenic flanking sequences, Table S2). This
new ten factor ChIP-Seq data set, therefore, provides a uniquely
powerful resource for the future characterization of target genes
for these ten major hematopoietic regulators as well as the
characterization of regulatory networks in HSPCs. For the
remainder of this manuscript, we illustrate how this new data
set can provide insights into combinatorial transcriptional control
mechanisms in HSPCs.
Genome-wide Analysis Identifies Preferential
Transcription Factor Binding Pairs
Having generated genome-wide maps for ten important regula-
tors of HSPCs, we reasoned that comprehensive bioinformatic
analysis of this unique data set might allow us to obtain new
insights into combinatorial transcription factor interactions.
Visual inspection of individual gene loci demonstrated a wide
variety of combinatorial binding patterns (Figure 2). For example,
the +1 HSPC enhancer of the Hhex gene (Donaldson et al., 2005)
was bound by all ten TFs (Figure 2A), whereas multiple peaks
bound by different combinations of TFs were seen in the
Zfpm1/Fog1 gene locus (Figure 2B).
Given the large scale of genome-wide data sets, inspection of
specific gene loci is completely impractical for discovering glob-
ally important combinatorial TF patterns. In order to identify such
control mechanisms, we first asked whether the frequency of
colocalization of transcription factor pairs on the same target
regions was greater than would be expected by chance, thus
indicating preferential coregulatory activities. To this end, we
determined the number of overlapping peaks for all 45 possible
pair-wise combinations (Figure 3). This analysis identified
overlapping binding events for all pair-wise combinations but
did not address whether the observed overlaps were statistically
significant. To get an estimate of the total available space for
transcription factor binding in HPC-7 cells, we performed
a ChIP-Seq experiment using an antibody against acetylated
histone H3 (Histone H3 lysine 9 and 14), which allowed us to
define 46598 regions of enriched histone acetylation. We then
determined the total number of regions that were acetylated
and/or bound by at least one of the ten factors (e.g., the union
of acetylation and transcription factor peaks), which resulted in
a total of �80,000 unique peaks. This number is similar to
the �100,000 DNase I sites reported in human CD4 T cells and
lymphoblastoid cells (Boyle et al., 2008; McDaniell et al., 2010).
100,000 was, therefore, used as an estimate of the number of
potentially available regions for binding for the ten TFs. Using
the observed numbers of peaks for each of the ten factors, we
performed simulations (1000 iterations) to determine how many
regions would be expected to be co-occupied by chance for
any pair of factors. This bootstrapping exercise demonstrated
that some overlaps were much more significant than others
and that all pairs except those involving PU.1 occur more often
than expected by chance. Many of the most significant overlaps
were observed for pairs involving known partners, such as SCL/
LMO2/LYL1/GATA2, or closely related family members, such as
Erg/Fli-1. Interestingly, pairs of factors not previously thought to
collaborate showed equally high significance, particularly those
involving RUNX1 with either SCL, LYL1, LMO2, or GATA2
(Figure 3 and Figure S2).
SCL/LYL1/LMO2/GATA2 are known to bind as components of
multiprotein complexes to regulatory elements (Anguita et al.,
2004; Wadman et al., 1997), but our analysis suggests that there
may also be close collaboration between factors not previously
known to operate together, such as SCL/RUNX1, GATA2/
RUNX1, LYL1/RUNX1, and also RUNX1/LMO2. To further inves-
tigate the likelihood of cooperative TF binding, we determined
the relative distances for all pair-wise binding events taking
advantage of the fact that ChIP-Seq peak calling algorithms
are highly accurate at identifying peak summits (Zhang et al.,
2008). This analysis demonstrated that the median distance for
all 45 pairs was variable and ranged from 22 bp (LYL1 4
LMO2) to 85 bp (PU.14 GFI1b). As different members of the
same TF family (e.g., PU.1/FLI-1/ERG and SCL/LYL1) would
be expected to often bind to the same site within a given popu-
lation of cells, we grouped all ‘‘within family’’ comparisons and
then ranked all ‘‘across family’’ comparisons based on their
median distance (Figure 3B). This analysis demonstrated that
median distances between peak centers for pair wise
combinations that involved PU.1, Gfi1b, and Meis1 were larger
than those for ‘‘within family’’ comparisons, whereas all other
combinations were within the same range (Figure 3B). Reassur-
ingly, known partners were identified within this analysis, such as
SCL/LMO2, GATA2/LMO2, and GATA2/ERG or GATA2/FLI-1.
However, previously unknown potentially collaborative
binding was also identified between SCL/RUNX1 or LYL1/
RUNX1, which together highlighted a potential new HSPC regu-
latory complex composed of SCL, LYL1, LMO2, GATA2,
RUNX1, ERG, and FLI-1.
Characterization of Wider Combinatorial Interactions
among HSPC Transcription Factors
Having identified potential interplay between seven factors from
pairwise analysis, we next interrogated whether an examination
of wider combinatorial interactions would corroborate these
initial observations. To analyze combinatorial patterns in an
unbiased fashion, we performed principal component analysis
(PCA) and hierarchical clustering (see Experimental Procedures)
of all regions bound by five or more factors (Figure 4). Analysis of
the ten factor multivariate data set by PCA revealed close corre-
lation between GATA2/SCL/LYL1 and ERG/FLI-1 occupancy
patterns with RUNX1 and LMO2 situated near these two
clusters. PU.1, GFI1B, and MEIS1 binding patterns, on the other
hand, were all found to be much more separated from the other
seven factors.
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To corroborate these findings using an independent mathe-
matical approach, we also analyzed occupancy patterns using
hierarchical clustering. Interestingly, this analysis also separated
the ten factors into two major clusters separating the TFs in the
samemanner as analysis of peak summit distances from the pair
wise comparisons and PCA (e.g., MEIS1/GFI1B/PU.1 versus
LYL1/GATA2/RUNX1/SCL/LMO2/FLI-1/ERG). Taken together,
therefore, our comprehensive bioinformatic analysis suggests
that close combinatorial interactions among seven regulators
(SCL, LYL1, LMO2, GATA2, RUNX1, FLI-1, and ERG) play an
important role in HSPC transcriptional control. Although all of
these TFs are known to be important individually for HSPCs,
our unbiased bioinformatic analysis implicates all seven factors
together as being extensively involved in cooperative transcrip-
tional control.
Genome-wide Analysis of Coordinated Binding of LYL1,
SCL, LMO2, GATA2, RUNX1, FLI1, and ERG
Statistically significant pairwise co-occupancy, close proximity
of binding, and combinatorial clustering all highlighted a heptad
of transcription factors important for HSPCs (SCL, LYL1, LMO2,
ERG, FLI-1, GATA2, and RUNX1). We, therefore, investigated
co-occupancy involving these seven factors further. There
were 1015 regions where all seven factors were bound within
200 bp or less. De novo motif discovery on this set of sequences
recovered the consensus binding motifs for all seven factors, as
well as one additional overrepresented motif. We were unable
to identify a cognate binding factor for this latter motif, but
a similar motif has previously been recovered from a purely
computational genome-wide analysis of conserved noncoding
sequences (Xie et al., 2007) (Figures 5A and B). Recovery of all
Figure 2. Specific Gene Loci Exhibit a Wide Variety of Combinatorial Binding Patterns
RawChIP-Seq read datawere transformed into a density plot for each TF and loaded into theUCSCgenomebrowser as custom tracks above theUCSC tracks for
gene structure andmammalian homology. Visual inspection of gene loci showedmany different combinations of binding for the ten different transcription factors.
Displayed here are two loci that havebeen tested previously in transgenicmice (Donaldson et al., 2005;Wilson et al., 2009). (A) Hhex. (B)Zfpm1/Fog1. Screenshots
for ten additional gene loci are provided as Figure S2. Real-time PCR validation of ChIP material in HPC-7 and E11.5 FL can be found in Figure S2.
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expected consensus motifs underlines the high quality of the
data sets produced in the current study. Moreover, identification
of only a single additional motif suggests that the set of factors
analyzed in this study provides most of the regulatory context
of regions bound by the SCL/LYL1/GATA2/RUNX1/LMO2/
FLI-1/ERG heptad.
While de novomotif discovery identifies statistically overrepre-
sented motifs within a sequence collection, it does not directly
address the question of motif presence/absence or the presence
of motif combinations in individual sequences. To address this
issue, we mapped Ets, GATA, E-box, and Runx consensus
sequences across all regions bound by the seven factors and
performed hierarchical clustering to recover potential combina-
torial patterns. This analysis demonstrated that the vast majority
of heptad-bound peaks contained GATA and Ets sites (Fig-
ure 5C). By contrast, only 76% contained an E-box and even
less (39%) contained a Runx consensus motif, indicating poten-
tially indirect binding of E-Box and RUNX transcription factors
to a significant proportion of regulatory elements. Of note,
each region contained at least one of the four motifs, and over
99% contained at least two. Taken together, this analysis dem-
onstrates that expected motifs are present in heptad-bound
regions but also suggests that RUNX1 and SCL/LYL1 may be
recruited indirectly to many elements.
The SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG
Heptad Displays Previously Unrecognized Protein-
Protein Interactions
Comprehensive analysis of our ten factor ChIP-Seq data high-
lighted a preference for SCL/LYL1/GATA2/LMO2/ERG/FLI-1/
RUNX1 to bind in close proximity to each other to specific
DNA sequences. This observation is suggestive of cooperative
binding, especially in the light of the absence of bona fide
Runx1 and Scl/Lyl1 binding motifs in a substantial number of
regions. Such cooperative binding would likely be facilitated by
extensive protein-protein interactions. Previous studies have
reported interactions between GATA2/LMO2/LYL1/SCL and
also GATA2/FLI-1/ERG, yet no interactions involving RUNX1
and other heptad members have been reported in HSPCs. To
investigate protein interactions between RUNX1 and other
complex constituents, we performed coimmunoprecipitation
(Co-IP) experiments for RUNX1, SCL, ERG, and GATA2 (Fig-
ure 6A). Following transfection of myc-tagged Runx1 and flag-
tagged Scl, lysates were immunoprecipitated using an anti-
Flag antibody, and immune complexes were analyzed using an
anti-Myc antibody to detect the presence of coimmunoprecipi-
tated RUNX1. Protein complex formation between SCL and
RUNX1 can clearly be seen in Figure 6Ai, which only shows the
presence of RUNX1 when both SCL and RUNX1 have been
expressed together. To further test whether other transcription
factors bound within the heptad could act as further docking
factors for RUNX1, additional Co-IP experiments were per-
formed. A combination of myc-tagged RUNX1 and ERG or
myc-tagged RUNX1 and GATA2 were transfected and immuno-
precipitated. Immune complexes were then analyzed using
either an anti-myc or an anti-ERG antibody (Figures 6Aii and
6Aiii, respectively). Prominent interactions between RUNX1
and GATA2/ERG were seen when the relevant TFs were
coexpressed, consistent with the notion that protein-protein
interactions facilitate binding of RUNX1 to those heptad-bound
regions that lack Runx1 consensus binding motifs (Figure 6B).
GATA2/RUNX1 Compound Heterozygous Mice
Are Not Viable with Severe Hematopoietic Defects
at Midgestation
Constituents of the new HSPC heptad, such as RUNX1 or
GATA2, are individually essential for the development of
Figure 3. Genome-wide Analysis Identifies Preferential Transcrip-
tion Factor Binding Pairs
(A) Shown at the top is the total number of peaks for each factor followed by all
45 possible pairwise combinations (number of overlapping peaks). To obtain
a measure for the significance of pairwise overlaps, bootstrapping was
performed (see Experimental Procedures) to calculate Z scores with increased
color intensity of shading indicating increasingly higher Z scores (a full color
coded legend and actual Z scores can be found in Figure S2).
(B) Box plots showing the distances (in bp on the y axis) between peak
summits for all 45 lists of pairwise overlaps from (A). Pairwise combinations
of the 10 TFs were separated into three groups: within TF families (shaded in
green), across families with median distance equal to or below that of ‘‘within
family’’ pairs (shaded in red), and across families with median distance greater
than for the ‘‘within family’’ comparisons (shaded in blue).
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definitive hematopoietic cells (Cai et al., 2000; Okuda et al.,
1996; Tsai et al., 1994; Wang et al., 1996). However, heterozy-
gous Gata2+/ and Runx1+/ mice are viable with only minor
hematopoietic phenotypes (Cai et al., 2000; Ling et al., 2004;
Rodrigues et al., 2005; Sun and Downing, 2004). Cooperative
control of important common target genes would suggest that
Gata2+/::Runx1+/ compound heterozygousmicemight display
a much more severe phenotype than animals heterozygous for
a single gene only. To investigate potential consequences of
Gata2/Runx1 compound heterozygosity,Gata2+/ and Runx1+/
micewere intercrossed (Figure 6C). Interestingly, after numerous
matings, only offspring which were heterozygous for either
Runx1 or Gata2 were viable, which occurred at a normal ex-
pected Mendelian ratio. By contrast, no Gata2+/::Runx1+/
animals were found, even though one quarter of all offspring
would be expected to be compound heterozygous (p = 0.004).
These results, therefore, demonstrate that Runx1+/ and
Gata2+/ function as classical synthetic lethal alleles, which are
widely recognized as genetic evidence of buffering relationships
between genes that function in common pathways.
To examine a possible hematopoietic phenotype of
Gata2+/::Runx1+/ compound heterozygous mice, colony
assays were performed on fetal livers (FL) from embryonic (E)
day 12.5 to determine the total number of clonogenic progenitor
cells (colony forming unit-culture [CFU-C]) per FL (Figure 6D). As
reported previously, CFU-Cs were compromised in Runx1+/
and Gata2+/ fetal liver when compared with wild-type (data
not shown). Interestingly, the number of CFU-Cs was reduced
even further in fetal livers from compound heterozygous
embryos (Figure 6D), which was paralleled by a significant
reduction in overall cellularity (see Figure S3). Furthermore,
gene expression analysis demonstrated the expected reduc-
tions in Gata2 and Runx1 levels for heterozygous samples and
expression changes specific for the Gata2+/::Runx1+/
compound heterozygous samples for some GATA2/RUNX1
targets, such as Meis1, Lyl1, Zfpm1/Fog1, Scl/Tal1, Gfi1b, and
Tet2 (see Figure S3). Whether any of these expression changes
are responsible for the phenotype of Gata2+/::Runx1+/
compound heterozygous embryos will be the subject of future
investigations. Taken together, genetic analysis allowed us to
identify interplay between two of the most powerful regulators
of HSPC function and, therefore, demonstrate the power of
comprehensive bioinformatic analysis of large genome-scale
data sets for generating new biological insight.
Integrated Analysis of the Ten Factor ChIP-Seq
Resource with External Data Generates
New Hypotheses
The utility of a resource, such as the ten-factor ChIP-Seq data
set described here, ultimately depends on how readily it can
be accessed by other scientists to analyze their own data and
gain novel insights. To provide a couple of vignettes of the types
of analysesmade possible, we present below integrated analysis
Figure 4. Characterization of Wider Combinatorial Interactions
among HSPC Transcription Factors
(A) Principle component analysis (PCA) identifies preferential combinatorial TF
associations. All genomic regions bound by five or more TFs were listed in
a ten-column table with 0/1 indicating absence/presence of each of the 10
TFs. PCA was performed and displayed using the R software environment
(http://www.r-project.org/). The plot shown displays the first three principle
components on the x, y, and z axis, with each colored dot corresponding to
the relative location of the TF indicated on the left.
(B) Hierarchical clustering of all genomic regions bound by 5 or more TFs
based on factor occupancy patterns. Themajor partition of columns separates
the 10 TFs into two main branches, with MEIS1/GFI1B/PU.1 to the left and
SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG to the right. Each line corre-
sponds to an individual genomic region where blue/white coloring indicates
the presence/absence of the given TF. Peak regions for individual TFs were
set at a standard width of 400 bp, and after merging overlapping regions,
the average size was 460 bp ± 260 bp. PCA and hierarchical clustering identify
overlapping specific multifactor associations, such as the FLI1/ERG/LMO2
triplet or the LYL1/GATA2/RUNX1/SCL/LMO2/FLI-1/ERG heptad. (See
Table S3 for list of heptad peaks).
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of the ten-factor ChIP-Seq data with both external expression
and single factor ChIP-Seq data. Given the wealth of high quality
gene expression profiles generated by other labs, we first asked
whether the 927 genes next to peaks bound by the heptad
showed positive enrichment for HSC-specific expression. To
this end, we performed gene set enrichment analysis (GSEA)
by loading microarray expression data from the hematopoietic
fingerprints database (Chambers et al., 2007) and the GNF
Gene Atlas (Wu et al., 2009) into the standalone GSEA program
(http://www.broadinstitute.org/gsea/) and then used the 927
genes next to heptad-bound peaks as the query gene set. The
heptad gene set showed highly significant enrichment for HSC
specific expression with both data sets (See Figure 7A), which
was not seen with three randomly chosen control gene sets
(Figure S4). Moreover, Gene Ontology analysis demonstrated
that a substantial proportion of the 927 heptad targets are
involved in transcriptional control, signaling, cell death, and cell
cycle (Figure 7B). These results, therefore, suggest that the
heptad target gene set (see http://hscl.cimr.cam.ac.uk/
ChIP-Seq_Data/ChIP-Seq.html) represents a rich source of
potentially new regulators of HSCs.
We next explored the value of integrating single-factor ChIP-
Seq data with our ten-factor resource. Given that SCL/GATA
complexes were originally discovered between SCL and the
erythroid factor GATA1 (Osada et al., 1995), we asked whether
there are any potential correlations between regions bound by
GATA1 in erythroid cells and those bound by SCL and its ortho-
log LYL1, as well as GATA2, in HPC-7 cells (Figure 7C). A recent
Figure 5. Motif Analysis Highlights the Core Regulatory Context of the Regions Bound by the SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG
Heptad
(A) De novo motif discovery performed on the set of regions bound by the SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG heptad identified Ets, GATA, E-box, and
Runx motifs precisely corresponding to the four motifs that would be expected for these seven factors.
(B) De novo motif discovery also highlighted one additional novel motif with no match to known TF binding motifs but significant similarity to a motif of unknown
function (LM90) identified through genome-wide computational analysis of noncoding conserved sequences (Xie et al., 2007).
(C) Hierarchical clustering of all regions bound by the SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG heptad based on the presence (white) or absence (red) of
expected consensus DNA binding motifs. Consensus binding sites were mapped using TFBSSearch (Chapman et al., 2004). A significant proportion of regions
did not contain Runx (TGYGGT) and/or E-box (CANNTG) consensus bindingmotifs, whereas most regions contain GATA and Ets (GGAW) sites. (See Table S4 for
list of peaks and associated genes which do not contain either an E-box or a Runx motif).
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genome-wide ChIP-Seq analysis of Gata1 in the erythroid model
cell line G1E-ER4 identified 14,351 peaks bound by GATA1 in
erythroid cells (Cheng et al., 2009). We used this data set to
ask what proportion of the regions bound by combinations of
SCL, LYL1, and GATA2 in HPC-7 would, later on in differentia-
tion, be bound by GATA1. As shown in Figure 7D, those regions
bound by both GATA2 and SCL in HPC-7 aremuchmore likely to
be bound by GATA1 than any of the other subsets. In contrast to
Figure 6. The SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG Heptad
Displays Previously Unrecognized Protein-Protein as Well as
Genetic Interactions
(A) Identification of protein-protein interactions between RUNX1-SCL,
RUNX1-GATA2 and RUNX1-ERG. Expression constructs were transfected
into 293T cells and putative protein interactions assayed by coimmunoprecipi-
tation/western blot analysis. (Ai) aFLAG immunoprecipitation (SCL), followed
by western blot using aMYC-tag antibody (RUNX1), demonstrates coimmuno-
precipitation of Runx1 by the aSCL (Flag) antibody. Awestern blot of lysates on
the right is shown as expression control. (Aii) aGATA2 immunoprecipitation,
followed by western blot using aRUNX1 (myc), demonstrates coimmunopreci-
pitation of Runx1 by the aGATA2 antibody. (Aiii) aMYC immunoprecitation
(Runx1), followed by western blot using a-ERG, demonstrates coimmunopre-
cipitation of ERG by the aRUNX1 (myc) antibody.
(B) Schematic of heptad proteins bound to DNA. Previously known protein
complexes are shown bound to DNA, and the newly identified links between
RUNX1 and SCL/GATA2/ERG are indicated by green arrows. The order of
proteins shown is for illustrative purposes rather than reflecting a particularly
common arrangement of binding sites.
(C) Expected and actual numbers of progeny from the Runx1+/ 3 Gata2+/
crosses. The failure to obtain live Runx1+/::Gata2+/ compound heterozygote
animals is highly significant (p = 0.004, c2 test).
(D) Colony assays on fetal livers from Runx1+/, Gata2+/ and Run-
x1+/::Gata2+/ E12.5 embryos. The data shown correspond to three, four,
and six livers, respectively, each analyzed in duplicate. Fetal livers from
compound heterozygous embryos give rise to fewer colonies than those
heterozygous for just a single gene. (See Figure S3 for differences in cellularity
of E12.5 fetal livers and qRT-PCR expression analysis of WT, Runx1+/,
Gata2+/, and Runx1+/::Gata2+/ fetal liver samples).
Figure 7. Integration of the Ten-Factor ChIP-Seq Resource with
External Data
(A) Gene set enrichment analysis (GSEA) demonstrates highly significant HSC
specific expression for the 927 candidate target genes of the SCL/LYL1/
GATA2/RUNX1/LMO2/FLI-1/ERG heptad. GSEA was performed using stan-
dard settings with two independent expression profiling compendia (Cham-
bers et al., 2007; Wu et al., 2009). The graphical outputs show enrichment
(green curve) of the heptad gene set along ranked lists of all genes ordered
based on their HSC-specificity of expression in the two data sets.
(B) Analysis of putative gene function for 927 heptad target genes reveals an
abundance of genes involved in transcriptional control and signaling.
(C) SCL, LYL1, andGATA2 binding combinations in HPC-7 cells (Venn diagram
showing the numbers of peaks bound by combinations of SCL, LYL1, and
GATA2).
(D) Peaks bound by both SCL and GATA2 in HPC-7 cells are commonly bound
by GATA1 in erythroid cells. The bar chart shows the proportion of all regions
shown in (C) that are bound by GATA1 in erythroid cells (GATA1 peak data
taken from Cheng et al. [2009]); S, SCL; L, LYL1; G, GATA2.
(E) Gene set enrichment analysis (GSEA) identifies subsets of genes next to
peaks bound by both SCL and GATA2 with erythroid-specific expression.
Neighboring genes were determined for the SG, SL, LG, and SLG peak
categories from (D), and GSEA was performed using standard settings.
Erythroid specificity of gene expression was determined by comparing
erythroid expression to the eight other mature cell types present in the hema-
topoietic fingerprints database (Chambers et al., 2007). (See Figure S4 for
GSEA analysis with control gene sets).
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LYL1, SCL is a key regulator of erythropoiesis, where it
commonly functions in SCL/GATA1 containing multiprotein
complexes. Our data, therefore, suggest that these functional
differences between SCL and LYL1 are already apparent in the
set of target regions bound differentially by SCL and LYL1 in
progenitors. Moreover, our results are consistent with the notion
that a significant proportion of those regions bound later on by
SCL/GATA1 are already ‘‘primed’’ by SCL/GATA2 binding in
progenitors.
To further corroborate potential priming of erythroid loci by
SCL/GATA2, we determined the genes next to peaks bound by
SCL/GATA2, SCL/LYL1, LYL1/GATA2, and SCL/LYL1/GATA2
and performed gene set enrichment analysis. Comparison of
the various peak classes demonstrated that only those genes
next to peaks bound by SCL and GATA2 (and, therefore, more
likely to be bound by GATA1 later on) showed a modest but
nevertheless significant enrichment for erythroid specific
expression (Figure 7E). This analysis illustrates, therefore, how
integrated analysis of ChIP-Seq peak regions might be utilized
to predict gene function (e.g., that SCL has a major erythroid
phenotype, whereas LYL1 does not). Moreover, by linking differ-
entially-bound ChIP-Seq peaks to neighboring genes, this anal-
ysis also provides possible candidate target genes responsible
for the different functions of Scl and Lyl1. Taken together, there-
fore, the above examples demonstrate that the ten-factor ChIP-
Seq resource reported here can be integrated readily with
external data, such as expression or ChIP-Seq profiling, to
provide a wealth of novel hypotheses.
DISCUSSION
Identification of the ‘‘rules’’ that govern gene expression in stem
cells is of fundamental scientific and clinical significance. Here,
we report genome-wide binding patterns for ten key regulators
of HSPCs. Comprehensive bioinformatic analysis of combinato-
rial binding profiles suggested new direct functional links
between some of these vital regulators of HSC function, which
were validated using both cell biological/biochemical as well
as knockout mouse in vivo approaches.
Extracting Biological Insights from ChIP-Seq Analysis
Single-protein ChIP-Seq studies reporting long lists of binding
peaks often provide only limited scientific insights because there
are far too many putative candidate target genes to provide
specific new biological functions for the upstream regulator
under investigation. The challenge, therefore, remains to
develop widely applicable strategies for extracting biological
meaning from genome-wide ChIP-Seq data. Studies in lower
model organisms, such as yeast and Drosophila, have demon-
strated that the true power of genome-wide TF binding studies
may only be revealed by studying multiple factors together. For
example, determination of genome-wide binding patterns for
a near-full complement of yeast transcription factors has served
as an important cornerstone for the development of regulatory
network models of unprecedented scale and substantial predic-
tive power (Lee et al., 2002). In addition, a genome-wide survey
of five TFs over a time series of 15 developmental stages of
Drosophila mesoderm development demonstrated that spatio-
temporal gene expression patterns could be predicted with
accuracy from clustered TF binding patterns (Zinzen et al.,
2009). Similarly, a computational framework to predict absolute
as well as differential gene expression from comprehensive
mouse ESC ChIP-Seq data collections has recently been
proposed (Ouyang et al., 2009), and a comprehensive resource
of ESCs modified to express affinity-tagged transcription factor
proteins has recently been reported (Nishiyama et al., 2009).
The study reported here demonstrates that comprehensive
bioinformatic analysis of multifactor ChIP-Seq data has the
power to reveal new insights into combinatorial transcriptional
control mechanisms in complex mammalian settings.
Apart from the clear limitations of single-factor surveys, another
important consideration for ChIP-Seq studies is the homogeneity
of the starting population, which presents particular challenges
with rare and heterogeneous adult stem/progenitor cells. The
success of downstream bioinformatic analysis heavily depends
on sample homogeneity, and therefore, recent studies using
even much less challenging experimental systems, such as
mature erythroid or T cells, have opted for the use cell line systems
(Cheng et al., 2009; Fujiwara et al., 2009; Soler et al., 2010; Yu
et al., 2009). Importantly, we had previously validated Scl-bound
regions in the multipotential progenitor cell line HPC-7 as bona
fide early hematopoietic enhancers using extensive transgenic
mouse studies (Wilson et al., 2009). These demonstrated that 10
out of 11 regions boundbyScl had fetal liver activity. Four of these
ten (situated in theErg,Gfi1b,Klf2, andNfe2 loci, respectively) are
bound by all seven factors, and all four not only have fetal liver
activity, but also display specific staining within the midgestation
dorsal aorta region (data not shown) where HSCs emerge at this
time point during mouse embryogenesis (de Bruijn et al., 2000).
Further evidence of the validity of our experimental systemcomes
from our analysis of the genes next to peaks bound by the newly
identified heptad of SCL, LYL1, LMO2, GATA2, RUNX1, ERG,
and FLI-1. Gene set enrichment analysis (Subramanian et al.,
2005) demonstratedhighly significant enrichment ofgenesspecif-
ically expressed in HSCs, as well as signaling and transcriptional
regulatory proteins and was, therefore, consistent with the notion
thatgenescontrolledby thisheptadarecritical regulatorsofHSPC
function. Taken together, therefore, the data presented here
suggest that integrated analysis of ChIP-Seq results for multiple
factors has the potential to identify the key downstreammediators
of cellular phenotypes in complex mammalian systems.
Identification of Transcriptional Control Mechanisms
in HSPCs
Initial insights into gene regulatory mechanisms in HSPCs came
from studies of regulatory elements specifically active in HSPCs,
such as the Scl +19 or RUNX1 +23 enhancers (Landry et al.,
2008; Nottingham et al., 2007; Sa´nchez et al., 1999). Detailed
functional analysis demonstrated synergistic activation by
protein complexes containing the GATA factor GATA2 and Ets
factors FLI-1 or ERG (Go¨ttgens et al., 2002). Subsequent compu-
tational analysis based on evolutionarily conserved TF binding
motifs identified three structurally related elements with similar
in vivo activity leading to the hypotheses that an Ets/Ets/Gata
regulatory code plays a significant role in HSPC transcriptional
control (Donaldson et al., 2005; Pimanda et al., 2007a). However,
because of their short length and degeneracy, TF consensus
binding sequences occur many more times in mammalian
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genomes than there are genuine regulatory sites. Consequently,
genome-wide computational characterization of transcriptional
target sites has remained an elusive proposition. The data pre-
sented here show that multi-TF ChIP-Seq provides a much
more promising route toward gaining a comprehensive view of
transcriptional control mechanisms. Indeed, the most compel-
ling reason why computational screens will struggle lies in the
absence of recognized consensus binding sites in many regions
that are nevertheless bound by the relevant TFs in vivo, as
observed here for SCL/LYL1 and RUNX1.
Absence of conventional binding sites suggests tethering by
other factors. This is precisely what was shown previously
through a series of elegant studies where GATA1 was implicated
into recruiting SCL to DNA in erythroid cells because a mutant
Scl protein devoid of its own DNA binding domain could be
detected on regions also bound by GATA1 (Kassouf et al.,
2008). Given that Runx consensus binding motifs were absent
in an even greater proportion of heptad-bound regions than
E-boxes, we postulated that RUNX1 might also be recruited to
DNA by interacting with other TFs. However, it was not known
whether components of SCL/GATA2 complexes can interact
with RUNX1 and, thus, contribute to its tethering to DNA.
In this study, we provide evidence not only for biochemical but
also genetic in vivo interaction between RUNX1 and compo-
nents of SCL/GATA2 complexes. Bioinformatically informed
functional validation, therefore, provided previously unrecog-
nized links between some of the most powerful regulators of
HSC fate.
Combinatorial Control Mechanisms in HSPCs
The potential for different combinatorial interactions within
complex transcriptional regulatory networks is truly immense.
Even with only ten factors such as the set reported in this study,
there are 210 (1,024) different possible binding patterns based on
simple present/absent calls for each of the ten factors. In reality,
the situation is going to be much more complex still; not only
because additional factors will play a role but also because
quantitative effects are likely to be important (e.g., regions bound
strongly by both SCL and PU.1 may be functionally distinct from
those bound more strongly by SCL than PU.1). For the current
study, we focused our analysis on pairwise binding as well as
those regions bound by five or more factors. However, the
data set readily permits analysis of any other combinatorial
pattern that may be of interest to the wider community, including
any one of the 120 possible three-way and 210 possible four-way
combinations. The data presented here, therefore, represent
a platform for very substantive future investigations into the
function of ten critical regulators of HSPC function.
When faced with the prospect of having to explore potentially
huge numbers of combinatorial patterns such as the 1024
possible occupancy patterns for the 10 factors studied here, it
is salient to bear in mind that rigorous statistical analysis of the
experimental data can reduce significantly the number of
patterns when used as a means of prioritization. For example,
of the 1024 patterns possible with our ten factors, 221 are found
much more often than would be expected by chance (p < 0.01),
and importantly, many of these ‘‘overrepresented’’ patterns are
closely related. Integrated analysis taking into account for
example expression patterns or biological functions of genes
associated with specific categories of peaks should serve to
further prioritize hypotheses for subsequent experimental
testing.
With respect to the particular combinatorial interaction
between RUNX1 and GATA2/SCL complexes explored here, it
is noteworthy that despite their apparent functional differences
during early hematopoietic development (Lancrin et al., 2009),
recent studies are consistent with overlapping functions once
the hematopoietic program is established. Deletion of RUNX1
in adult bonemarrow causes expansion of immature progenitors
with a concomitant reduction of long-term HSC activity (Grow-
ney et al., 2005), and Runx1+/ mice have increased numbers
of progenitors yet reduced numbers of LT-HSCs when
compared with wild-type mice (Sun and Downing, 2004).
At the same time, increased levels of GATA2 induce quiescence
of HSCs (Tipping et al., 2009) and SCL has also recently been
reported to be a positive regulator of HSC quiescence (Lacombe
et al., 2010). Taken together, therefore, these observations are
consistent with the notion that RUNX1, GATA2, and SCL collab-
orate by jointly controlling a set of genes critical for setting the
balance between quiescence and proliferation of HSCs. Given
that loss of function mutations of Runx1 have been found in
several types of leukemia (Osato, 2004), identifying the molec-
ular mechanisms responsible for controlling the expression of
such critical target genes in normal cells will have important
implications for our understanding of the molecular conse-
quences of aberrant transcriptional control in hematopoietic
malignancies.
The fundamental importance of combinatorial transcriptional
control of development is particularly well documented through
studies in model organisms such as sea urchin and Drosophila.
Of note, the Drosophila Gata and Runx factors Serpent and
Lozenge control key stages of blood development (Lebestky
et al., 2000) and a series of elegant experiments demonstrated
both genetic as well as direct protein-protein interactions
between Serpent and Lozenge (Waltzer et al., 2003). Moreover,
interactions between RUNX1 and GATA1 have been identified
as a potentially important transcriptional mechanism in mega-
karyocytic cells (Elagib et al., 2003; Wu et al., 2009; Xu et al.,
2006). These observations, therefore, not only emphasize the
deep evolutionary conservation of interactions between Gata
and Runx proteins but also highlight the potential for combinato-
rial interactions between different members of these two
transcription factor families in different cellular contexts. It will
be interesting to investigate to what extent larger combinatorial
interactions such as the SCL/LYL1/GATA2/RUNX1/LMO2/FLI-
1/ERG heptad identified here may be involved in controlling tran-
scription in these other lineages.
Concluding Remarks
Here, we report the genome-wide binding profiles for ten key
transcriptional regulators of HSPCs which will be of major
interest to researchers studying any one of these ten factors.
Moreover, generation of a unified data set from a single cell
type represents an important prerequisite to performing sophis-
ticated integrated analysis of combinatorial TF interactions. The
experimental data provided in this study serve as an illustration
of the potential power of such future investigations. Integrated
bioinformatic analysis prompted us to investigate interactions
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between RUNX1 andGATA2/SCL. Functional validation of bioin-
formatic predictions not only validated the overall approach but
also provided a significant advance of our understanding of
blood stem cells by establishing previously unrecognized and
functionally important interactions between some of the most
powerful regulators of blood stem cells.
EXPERIMENTAL PROCEDURES
Chromatin Immunoprecipitation
HPC-7 cells (Pinto do O et al., 1998) were grown in Stem Cell Factor, and ChIP
assays were performed as previously described using polyclonal antibodies
against acetylated histone H3 (Milipore 06-599), SCL (Santa Cruz,
sc12984x), LYL1 (Abcam, ab30334-200), GATA2 (Santa Cruz, sc9008x),
LMO2 (R&D, AF2726), RUNX1 (Abcam, ab23980-100), MEIS1 (Santa Cruz,
sc-10599x), PU.1 (Santa Cruz, sc-352x), ERG (Santa Cruz, sc354x), FLI-1
(Abcam, ab15289-500), GFI1B (Santa Cruz, sc8559x), and control nonspecific
rabbit IgG (Sigma I5006); see Supplemental Experimental Procedures formore
details. Each sample was amplified and sequenced using the Illumina 2G
Genome Analyzer, following manufacturer’s instructions. Sequencing reads
were mapped to the mouse reference genome using MACS (Zhang et al.,
2008), converted to a density plot, and displayed as UCSC genome browser
custom tracks. Raw sequence data, custom track (.wig) files, and peak/gene
tables can be downloaded from the NCBI Gene Expression Omnibus portal
(www.ncbi.nlm.gov/geo; accession number GSE22178).
Peak Calling
For all ten transcription factors, three peak finding programs were used with
the same parameters used for each factor. Parameters for programs were
as follows: Findpeaks—default setting for ChIP-Seq analysis, peaks with
FDR < 0.05 called; Peakseq—default setting; MACS—MACS was used with
the following command line parameters: mfold = 16, t size = 35, bw = 100,
pvalue = 1e9, g size = 2,200,000,000, no lambda. The overlap from the three
programs was then taken (1 bp minimum). MACS peak coordinates were used
as reference for further analysis. Regions that lie at the end of chromosomes
that were high in repeat regions were subtracted from the high-confidence
peak coordinates. Finally, all peaks were standarized to 399 bp wide based
on MACS summits and average length of ChIP DNA fragments. Distances
between overlapping peaks from pairwise TF comparisons were calculated
and plotted as box plots using R (http://www.r-project.org/).
Analysis of Complex Binding Patterns
Principal component analysis (PCA) was used to reduce the dimensionality of
the datamatrix. Ten TFswere plotted in a 3D scatter plot, corresponding to the
first three principle components. In R, the svd function was used for PCA and
scatterplot3d for the 3D scatter plot. Hierarchical Clustering was performed on
the data matrix in R using the hclust function with default parameters.
Euclidean distance was used for distance matrix calculations, and the
‘‘complete method’’ was used for clustering.
Motif Analysis
Formotif analysis, the middle 200 bpwas taken for all peak regions, and peaks
were excluded from analysis if they had more than 60% of repetitve
sequences. For de novo motif discovery, the MEME program (Bailey and
Elkan, 1994) was used with standard settings. Matches to consensus
sequences were determined as described using TFBSSearch (Chapman
et al., 2004). To simplify the result matrix, 0 was used when there were no sites,
and 1 was used if 1 or more sites were found. The resulting matrix was clus-
tered and displayed using the heatmap function in R.
Coimmunoprecipitation Analysis
293T cells were transiently transfected with expression plasmids using
Protransfection Mammlian Transfection System (Promega) and incubated
48 hr before analysis. Cells were lysed and cleared of debris and DNA. Super-
natants were precleared with IgG and protein G-agarose beads. Then, anti-
FLAG antibody (Sigma M2, F3165), anti-GATA2 antibody (SC-9008x), or
MYC-agarose (sc-90 AC) were added to all corresponding samples. The
immune complexes were washed, boiled for 10 min in sample buffer, and
analyzed by western blot. Antibodies used for western blot are as follows:
ERG (Santa Cruz, sc354x) or MYC (Santa Cruz, sc-90).
Colony Assays
Clonogenic progenitor cells within the FL cell populations were assayed in the
colony-forming unit culture (CFU-C) assay. Cells were plated in duplicate in
35 mm culture dishes in MethoCult M3434 (StemCell Technologies, London,
United Kingdom) according to the manufacturer’s instructions. Cultures
were grown at 37C, 5% CO2, and colonies were counted after 7 days
(Nottingham et al., 2007).
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New microarray data have been deposited into the NCBI Gene Expression
Omnibus portal under the accession number GSE22178.
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General discussion and future experiments
 HSCs are the cell type responsible for the generation and establishment of 
the blood tissue in an organism, through their two main characteristics: self renewal 
capacity and differentiation ability in to all the different blood cell types. These two 
characteristics establish them as the founders of the adult hematopoietic tissue. 
The understanding of the molecular events controlling the processes of differentia-
tion and self renewal, as well as the generation of the HSC population, are of major 
importance in the field of regenerative medicine, since they could suggest strate-
gies to manipulate different cell types (non-hematopoietic and/or hematopoietic) 
to change lineage fate and allow the acquisition of HSC properties. 
  Transcriptional control is one of the most important intracellular regulatory 
mechanisms for establishment of cell fate, identity and function. The transcription 
factor Gata2 is a major regulator of embryonic hematopoiesis. The exact role of 
Gata2 in the generation, differentiation and self-renewal of HSCs is still largely un-
known. In this thesis we provide insight into the role of Gata2 in HSCs during mouse 
development by testing the hematopoietic potential of Gata2 expressing cells. The 
direct analysis of viable Gata2 expressing cells is possible only through the use of a 
Gata2 reporter system. The previously existing Gata2-GFP reporter mouse model 
(Minegishi, Suzuki et al. 2003) resulted in detectable GFP expression, however the 
genetic insertion of the GFP gene yielded a Gata2 haploinsufficient state. It has 
already been shown by Ling et al. (Ling, Ottersbach et al. 2004) that Gata2 haploin-
sufficient embryos have a greatly reduced number of HSCs and these HSCs are also 
qualitatively defective, clearly proving that the level of expression of the transcrip-
tion factor is important for its physiologic function. This fact renders the Gata2-GFP 
reporter mouse model unsuitable for testing the potential of the Gata2 expressing 
cells under physiologic conditions. Thus the generation of a new tool was necessary 
- a new reporter mouse model in which the level of expression and the function of 
the transcription factor would be unaffected, allowing the prospective isolation of 
Gata2 expressing cells. For this reason we generated the Gata2-Venus ES cell and 
mouse model (described in chapters 2 and 3 of this thesis). 
Gata2: A role in hematopoietic cell generation?
 A few studies have provided functional data that help hypothesize about 
the role of Gata2 during embryonic hematopoiesis. The phenotypes of both Gata2-
/- and Gata2+/- embryos, showing significantly reduced numbers of HSCs and hema-
topoietic progenitor cells, imply that Gata2 plays a role in the generation of hema-
topoietic cells. Whether Gata2 controls the acquisition of hematopoietic fate from 
the hemogenic endothelial cells and/or some other processes in the endothelial 
to hematopoietic transition is not known. Nevertheless, Gata2 is expressed in the 
lateral mesoderm and endothelial cells of the paired dorsal aorta and also the en-
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endothelial cells of the dorsal aorta and hematopoietic cluster cells at the time-
points of hematopoiesis in the mouse embryo, indicating that Gata2 has a func-
tional role in these specific cell types. This fact, in combination with FACS analysis 
data presented in this thesis (chapter 3) which show that Gata2 is expressed in 
hemogenic endothelial cells, further supports the idea of Gata2 playing a role in 
the generation of hematopoietic cells from the hemogenic endothelial cell popula-
tion. If that suggestion is true, it is expected that Gata2 expressing cell populations 
would be enriched in hematopoietic progenitors and HSCs. Gene expression pro-
filing studies of various hematopoietic cell populations have already shown that 
Gata2 is expressed in high levels in cell populations enriched in HSC activity and in 
more primitive hematopoietic cell populations. Lower levels of Gata2 expression 
were observed in more mature cell subsets (Orlic, Anderson et al. 1995). In this 
thesis (chapter 3) we prove that Gata2 expressing cell population is highly enriched 
in hematopoietic progenitor cells and that all the HSCs are found in the Gata2 ex-
pressing cell fraction. The specific role of Gata2 in the HSC population is at present 
unknown.
 Evidence coming from imaging experiments further supports the sugges-
tion that Gata2 is involved in the generation of hematopoietic cells. Whole mount 
immunostaining results demonstrate that the Gata2-/- embryos have no intra-aortic 
clusters in the lumen of the dorsal aorta (DA), indicating that Gata2 is somehow 
involved in the process of hematopoietic cell generation. On the other hand c-Kit+ 
hematopoietic cells in the form of small hematopoietic clusters are present in the 
vitelline and the umbilical arteries. In addition, small numbers of hematopoietic 
progenitors can be detected by methylcellulose assays in the YS and the major vas-
culature of the Gata2-/- embryos. The presence of hematopoietic progenitors in the 
Gata2-/- embryos is further supported by the finding that hematopoietic progeni-
tors are always present in the Venus negative cell fractions of the hematopoietic 
tissues (this thesis, chapter 3).  The above mentioned findings clearly demonstrate 
that Gata2 independent progenitors exist in the embryos. This fact seems some-
what contradictory with the general idea about the importance of Gata2 function 
in hematopoietic cell generation. One possible explanation about the existence of 
these Gata2 independent hematopoietic progenitors in the Gata2-/- mice could be 
that Gata2 function is partially compensated by the binding of other Gata factors, 
since it is already shown from the literature that the same Gata binding sequences 
can be recognized by more than one Gata transcription factor (Takahashi, Shimizu 
et al. 2000; Grass, Boyer et al. 2003; Jing, Vakoc et al. 2008). Experiments examining 
whether other Gata factors are expressed in the relevant cells in embryo are neces-
sary to confirm this. Another hypothesis could be that these Gata2 independent 
progenitors which are also present in physiologic conditions (Venus negative cells) 
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represent hematopoietic progenitors of the first waves of progenitor generation 
before the emergence of the HSCs. Transcriptional profiling of these cells should 
provide some insight into this.
 To specifically identify the cell types in which Gata2 plays an important role, 
a conditional knock out approach can be followed. A similar approach has already 
been taken to examine in which cells the function of Runx1 - another major regu-
lator of hematopoiesis - is required. Chen and colleagues (Chen, Yokomizo et al. 
2009) proved that the role of Runx1 is localized in the endothelial to hematopoi-
etic transition in the midgestation embryo. Conditional knock out of the transcrip-
tion factor in vascular-endothelial-cadherin positive (VE-cad) cells resulted in loss 
of HSCs, hematopoietic progenitors and intraaortic cluster formation. The findings 
described in the Runx1 study raise a similar question concerning the role of Gata2, 
and its localized function in specific cell types and during a specific developmental 
window of time. At present, studies in our lab on the conditional knock out of Gata2 
in endothelial (driven by VEcad-Cre) or hematopoietic cells (driven by Vav-Cre) sug-
gest that Gata2 may have different and distinct roles during the different stages of 
hematopoietic development in the mouse embryo (manuscript in preparation by 
E. de Pater, data not shown). How Gata2 manages to perform the different tasks 
and different functions is still unknown. More studies need to be done towards the 
precise identification of Gata2 target genes and the protein partners of Gata2 in 
regulating gene expression in every different cell population. Technical limitations, 
with very small cell number in each population being the most important of them, 
still need to be surpassed in order to answer all these important questions.
 Different levels of Gata2 expression might define cell subsets with distinct 
potential or role
 As it has been mentioned previously, reduced levels of Gata2 affects he-
matopoietic cell generation/maintenance in the embryo as well as hematopoietic 
function in the adult (Ling, Ottersbach et al. 2004; Rodrigues, Janzen et al. 2005). 
Similar to Gata2, Runx1 also functions in a dose dependent manner, as it has been 
shown in experiments with Runx1+/- embryos (Robin, Ottersbach et al. 2006). The 
fact that both of these major regulators of hematopoiesis depend on the expres-
sion levels for their physiologic function suggest that there is a direct association 
between transcription factor levels and their role, and this seems to be an impor-
tant characteristic of the intrinsic regulation of hematopoiesis. This aspect raises 
the question of whether it is possible to use this attribute to define and isolate 
separate cell populations with distinct functions and potential based on the levels 
of transcription factor of expression. Studies with the PU.1 transcription factor in a 
reporter mouse model have already shown that varying levels of PU.1 expression 
can define distinct populations with different hematopoietic potential (Nutt, Met-
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calf et al. 2005). More specifically, high levels of PU.1 expression in hematopoietic 
progenitors are associated with the maintenance of the myeloid potential, whereas 
PU.1 downregulation leads to restriction in megakaryocyte and erythroid differen-
tiation. The test of this hypothesis for the Gata2 expressing cell population in the 
embryo and adult would be of particular interest because of its important role as 
a major regulator of hematopoiesis. Isolation of the Gata2 expressing cell fraction 
into subsets based on its expression levels could identify distinct cell populations 
with differential cell fate potential and function. Cell population discrimination and 
characterization should help the sub-categorization of the hematopoietic cells into 
a developmental and/or functional hierarchy. This is of particular importance since 
no single marker currently allows the discrimination of long and short term HSCs 
and hematopoietic progenitors in early embryonic hematopoietic development. 
Our preliminary FACS analysis results indicate that such discrimination is possible 
for the Gata2 expressing cells and that the HSC activity in the E14 and E16 FL can 
be localized in the Venus intermediate expressing cell population (chapter 3 of this 
thesis).
 The next step towards a more accurate characterization of a HSC cell popu-
lation would be the combination of our Gata2-Venus reporter mouse with other 
major regulators of hematopoiesis reporter mouse models like Runx1 and SCL. As 
part of my early thesis work, I initiated the construction of a Runx1 reporter with 
mKate fluorochrome gene, similar to the Gata2-Venus construct. This Runx1-mKate 
construct has been successfully recombined in ES cells and the creation of a mouse 
model will soon be underway. The combination of the Gata2-Venus and Runx1-
mKate models will allow the isolation of cells expressing both of the transcription 
factors. 
 The combination of both the multiple reporters with the differential gene 
expression discrimination and the addition of cell surface markers discrimination 
could be a major step towards the goal of isolation of a pure embryonic HSCs, he-
matopoietic progenitor populations or pre-HSCs. Gene expression profiling of pure 
cell populations and the comparison between them and between the cells they 
derive from, like hemogenic endothelial cells, would be a significant advancement 
towards the understanding of the molecular mechanisms controlling processes like 
HSC generation, proliferation and differentiation into more restricted lineages.
Gata2 expression is very dynamic
 All the above mentioned attributes of Gata2 have clearly emphasized that 
the timing and the level of expression are of major importance for the physiologic 
function of the transcription factor. The onset of Gata2-Venus expression in the he-
matopoietic sites and the following of the behavior of the individual cells express-
ing Gata2 can further provide us with information about the role and function of 
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A novel technique of time lapse imaging has been developed in order to demon-
strate specific cell behaviors like the endothelial to hematopoietic transition (Bois-
set, van Cappellen et al. 2010). Time lapse imaging of thick sections of the aorta at 
the important hematopoietic developmental stages, using Gata2-Venus embryos, 
will help in addressing of some interesting questions about the Gata2 expressing 
cells. Are they proliferating? Do they undergo endothelial to hematopoietic transi-
tions? Is the onset of Gata2 expression associated with specific functions like pro-
liferation or differentiation? More time lapse imaging videos need to be produced 
from different developmental timepoints to yield a better understanding of the be-
havior of the Gata2 expressing cells. What is already clear from the existing data 
is that Gata2 expression is very dynamic. The turning on and off as well as fluctua-
tions in the Venus expression have been observed in individual cells. Whether these 
fluctuations can be functionally associated with the fluctuations in other regulatory 
molecules like transcription factors or signaling molecules needs further investiga-
tion.
 The combination of the ¬Gata2-Venus reporter with the ¬Runx1-mkate in 
the future will provide an even further advantageous tool in addressing important 
questions like the onset of each transcription factor in specific cells and whether 
the expression of one affects the expression of the other. It will be interesting to 
observe whether endothelial to hematopoietic transitions can be observed from 
double expressing cells. Most importantly, the double reporter models will provide 
us with the opportunity to study the movements, behavior and the hematopoietic 
function of the cells simultaneously, singularly or sequentially expressing both of 
these pivotal transcription factors.
Gata2 works in a combinatorial manner with other transcription factors.
 One of the questions raised about function of Gata2 is its different and dis-
tinct roles, as suggested by our results in germline Gata2+/- and Gata2 conditional 
knock out embryos and adult mice. In the study by Wilson and colleagues  present-
ed in this thesis (chapter 4) the genome wide binding sites of ten key transcription 
regulators of hematopoiesis was investigated. Bioinformatics analysis of the data 
sets show that a heptad of transcription factors is very often bound in genomic se-
quences controlling hematopoiesis-related genes. These data also show that tran-
scription factors work in a combinatorial manner and it can be hypothesized that 
different combinations of transcription factors in a transcription factor “complex” 
might have different effects and serve different functions in hematopoietic cells. 
This mechanism can possibly explain the differential roles of Gata2 during develop-
ment in lateral mesoderm, endothelial and hemogenic endothelial cells, hemato-
poietic progenitors and HSCs. The formation of different transcription factor com-
plexes, based on the set of transcription factors expressed in a specific cell type at a 
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certain developmental timepoint, could lead to the transcriptional regulation of a 
distinct set of genes, thus controlling in this way various developmental processes. 
This combinatorial manner of gene regulation involving Gata2 together with the 
quantitatively different levels of Gata2 expression levels is likely to be the underly-
ing mechanism by which Gata2 exhibits distinct effects at different developmental 
timepoints.
 In conclusion, in this thesis we show that all HSCs in the embryo express 
Gata2. The Gata2 expressing cell population of the embryo and embryoid bodies 
is also enriched in hematopoietic progenitor activity. Thus, Gata2 is relevant to 
generation and maintenance of the adult hematopoietic system. We provide novel 
data proving the existence of Gata2 independent progenitors that may be helpful 
in understanding how the early wave of hematogenesis differs from the permanent 
adult wave. For the first time we show by time lapse imaging, that Gata2-Venus 
expression in the aortic endothelium and hematopoietic cluster cells is very dy-
namic at E10.5, suggesting the stochastic activation of target genes. Finally, in the 
Wilson et al. study we show that Gata2 works in combinatorial manner along with 
other transcription factors that are major players in hematopoietic regulation. As a 
major transcriptional regulator in HSCs and progenitors during embryonic develop-
ment, the relevance of Gata2 and its regulation and function in human health has 
been recently demonstrated (Johnson, Hsu et al. 2012). In this study the research-
ers describe the case of a patient with monocytopenia and mycobacterial infection 
syndrome (MonoMAC). MonoMAC can be caused by missense mutations or intra-
genic deletions of GATA2. In this case the causative mutation was the disruption of 
a conserved E-box-GATA composite element located in an intron (+9.5). The study 
revealed that disruption of this cis regulatory element in mice (+9.5-/- and +9.5+/-
) leads to impaired vascular integrity and also in hematopoietic defects different 
from those seen in Gata2-/- embryos. It seems that this deletion affects a specific 
cell subset of Gata2 expressing cells (definitive but not primitive). This study clearly 
demonstrates the importance of Gata2 expression in the normal physiologic func-
tion of human hematopoietic cells and highlights the need for further understand-
ing Gata2 regulation and function in adult hematopoiesis.
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Summary
 Hematopoietic stem cells (HSCs) are the most important cell type of the 
adult hematopoietic system. They produce the billions of new blood cells needed 
each day and are characterized by the abilities of self renewal and differentiation. 
Self renewal capacity is responsible for maintaining an intact pool of HSCs during 
the life span of an organism. Through differentiation, HSCs provide the organism 
with all the distinct hematopoietic cell types of the blood tissue. During embryonic 
development, the first adult type HSCs are generated in the aorta gonads meso-
nephros (AGM) region – embryonic day 10.5 in the mouse. The generation of the 
HSCs and their differentiation into more restricted hematopoietic progenitors is 
tightly controlled. The molecular mechanisms regulating these processes involve 
extrinsic and intrinsic regulators. Transcriptional factors are the most important in-
trinsic regulators of the HSCs generation and differentiation. Gata2 is a key tran-
scription factor controlling HSCs generation.
 To understand the role of Gata2 during embryonic hematopoiesis it is es-
sential to study the characteristics of the cells expressing Gata2. Until now it has 
not been feasible to isolate Gata2 expressing cells and test their potential in in vivo 
and in vitro functional assays or to follow them in vivo with live time lapse imag-
ing. To this end, I generated in my thesis research a new Gata2 reporter embryonic 
stem (ES) cell line and a mouse model in which Gata2 expression is followed by the 
expression of Venus fluorochrome. In this way the observation of Gata2 expressing 
cells is facilitated and their isolation has become feasible. 
 In Chapter 2 I describe the generation of this new ES cell reporter line and 
the embryoid body (EB) differentiation culture system used to explore the potential 
of Gata2 expressing cells. I show that Venus and Gata2 are coordinately expressed 
in our reporter line (G2V5) and further demonstrate that during hematopoietic 
differentiation of EBs Gata2 expressing cells also express endothelial and hema-
topoietic cell surface markers (CD31 and c-Kit, respectively). Prospective isolation 
of Gata2 expressing cells and functional assays show that they possess endothelial 
potential in matrigel cultures, and also highly enriched in hematopoietic differentia-
tion potential. 
 In Chapter 3 the generation of the Gata2-Venus reporter mouse model is 
described. I demonstrate that Gata2-Venus adult mice are hematopoietically nor-
mal and that Venus and Gata2 are coordinately expressed. Confocal microscopy of 
the mouse embryo shows that Venus fluorochrome expression is localized to the 
same anatomical regions and cells that have been shown to express Gata2 mRNA. 
Flow cytometric analyses of the hematopoietic anatomical sites show that Gata2 
expressing cells increase in numbers in the AGM and fetal liver (FL) during embryon-
ic development. Furthermore, the number of CD31+c-Kit+Venus+ intraaortic cluster 
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cells also  decrease between E10 – E11 in agreement with previously published 
data on cluster cells. Functional analyses of Venus sorted cell populations show that 
the Gata2 expressing cell fraction is highly enriched in hematopoietic progenitors. 
Hematopoietic progenitors were also observed in the Venus negative cell fraction. 
Hematopoietic progenitor assays performed on Gata2-/- embryonic tissues confirm 
that Gata2 independent hematopoietic progenitors exist. These results have been 
further validated by the identification of c-kit+ hematopoietic clusters in the vitel-
line artery (VA) of Gata2-/- embryos. Hematopoietic progenitor enrichment can 
be further enhanced by combining our Gata2-Venus mouse model with the Ly6A-
GFP reporter mouse. The identification of a small double positive cell population 
(GFP+Venus+) very highly enriched in immature hematopoietic progenitors. Impor-
tantly, HSC activity was found exclusively in the Gata2 expressing cell fraction.
 In Chapter 4 I present the genome-wide binding profile of ten transcription 
factors that have been shown to play an important role in regulating hematopoiesis. 
Bioinformatics analyses of these data sets suggest genome-wide combinatorial in-
teractions between these key regulators of hematopoiesis and also further suggest 
the existence of a “heptamere” of transcription factors associated with hemato-
poietic cells. These data suggest the existence of previously unidentified transcrip-
tion factors interactions. Finally, functional experiments in Gata2+/-Runx1+/- embryos 
show these two major hematopoietic regulators have a combined effect in their 
function, suggesting that the bioinformatics analysis data can be a useful tool in 
understanding transcription factors cooperation in regulating specific processes like 
hematopoiesis. 
 In brief, in this thesis I describe the generation of a new Gata2-Venus re-
porter mouse and ES cell line model that allows the identification of Gata2 express-
ing cells in vivo and their isolation for use in functional in vivo and in vitro assays. I 
show that all the HSC activity in the mouse embryo is found in the Gata2 expressing 
cell fraction and that this cell population is highly enriched in hematopoietic pro-
genitors. Gata2 is found to work in a combinatorial manner along with other major 
regulators of hematopoiesis. Most importantly, I show for the first time, by time-
lapse imaging, that Gata2 expression at E10 embryonic aorta undergoes dynamic 
changes. These studies have expanded our knowledge of Gata2 and the regulation 
of hematopoietic stem and progenitor cell development. 
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Samenvatting
 Hematopoietische stam cellen (HSCs) zijn de belangrijkste celtypes van het 
volwassen hematopoietische systeem. Zij produceren de miljarden nieuwe bloed-
cellen per dag en worden gekenmerkt door het vermogen van zelfvernieuwing en 
differentiatie. Zelfvernieuwing capaciteit is verantwoordelijk voor een intact poel 
van HSCs tijdens de levensduur van een organisme. Door differentiatie, verzorgen 
de HSCs het organisme met alle verschillende hematopoietische celtypes van het 
bloed weefsel. Tijdens de embryonale ontwikkeling, worden de eerste volwassen 
type HSCs gegenereerd in de aorta gonaden mesonephros (AGM) regio – op em-
bryonale dag 10,5 in de muis. Het genereren van de HSCs en hun differentiatie in 
meer beperkte hematopoëtische voorloper cellen wordt streng gecontroleerd. De 
moleculaire mechanismen dat deze processen regulieren worden aangestuurd door 
extrinsieke en intrinsieke regulatoren. Transcriptiefactoren zijn de belangrijkste in-
trinsieke regulatoren van de HSC generatie en differentiatie. Gata2 is een essentiële 
transcriptiefactor dat HSCs generatie aanstuurt.
 Om de rol van Gata2 tijdens de embryonale hematopoiese te begrijpen is 
het essentieel om de kenmerken van de cellen waar Gata2 actief is te bestuderen. 
Tot nu toe was het niet mogelijk om de cellen dat Gata2 tot expressie brengen te 
isoleren en te analyseren in in vivo en in vitro functionele assays of te volgen in vivo 
met live time lapse imaging. Te dien einde, heb ik in mijn proefschrift onderzoek 
een nieuwe Gata2 verslaggever embryonale stamcel (ES) cellijn en een muismodel 
gegenereerd waarin Gata2 expressie wordt gevolgd door de expressie van Venus 
fluorochroom. Op deze manier is de waarneming van Gata2 expressie brengende 
cellen en de isolatie ervan mogelijk gemaakt.
 In Hoofdstuk 2 beschrijf ik het ontstaan van deze nieuwe ES-cel reporter lijn 
en de embryoid body (EB) differentiatie kweek systeem dat wordt gebruikt om het 
potentieel van deze Gata2 expressie brengende cellen te verkennen. Ik laat zien dat 
Venus en Gata2 gecoördineerd to expressie komen in onze reporter lijn (G2V5) en 
toon bovendien aan dat gedurende hematopoietische differentiatie van EBs Gata2 
expressie brengende cellen ook endotheliale en hemopoëtische celoppervlakte 
eiwitten (CD31 en c-Kit, respectievelijk) bezitten. Prospectieve isolatie van Gata2 
expressie brengen cellen en functionele toetsen laten zien dat deze cellen endo-
theliale vermogen in Matrigel kweek systeem bezitten, en ook zeer verrijkt zijn in 
hematopoietische differentiatie vermogen.
 In Hoofdstuk 3 wordt het genereren van de Gata2-Venus reporter muismo-
del beschreven. Ik laat zien dat Gata2-Venus volwassen muizen zijn hematopoieti-
cally normaal en dat Venus en Gata2 worden gecoördineerd uitgedrukt. Uit con-
focale microscopie van de muis embryo blijkt dat Venus fluorochroom expressie is 
gelokaliseerd aan dezelfde anatomische regio en cellen waarvan aangetoond is dat 
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deze Gata2 mRNA expressie hebben. Flow cytometrische analyses van de hemato-
poietische lokaties laat zien dat Gata2 expressie brengende cellen in aantallen toen-
emen in de AGM en foetale lever (FL) tijdens de embryonale ontwikkeling. Bovendi-
en is het aantal CD31+c-Kit+Venus+ intraaortic cluster cellen nemen ook af tussen E10 
- E11 in overeenstemming met eerder gepubliceerde gegevens over cluster cellen. 
Functionele analyse van Venus gesorteerd celpopulaties laten zien dat de Gata2 ex-
pressie brengende cel fractie is sterk verrijkt in hematopoietische voorlopercellen. 
Hematopoëtische voorlopers werden ook waargenomen in de Venus negatieve cel 
fractie. Hematopoietische voorlopercel assays uitgevoerd op Gata2-/- embryonale 
weefsels bevestigen dat Gata2 onafhankelijke hematopoietische voorlopercellen 
bestaan. Deze resultaten werden verder bevestigd door de identificatie van c-Kit+ 
hematopoietische clusters in de vitelline slagader (VA) van Gata2-/- embryo’s. He-
matopoietische voorlopercel verrijking kan verder worden verbeterd door het com-
bineren van onze Gata2-Venus muismodel met Ly6A-GFP reporter muis. Met als 
gevolg, de identificatie van een kleine dubbele positieve celpopulatie (GFP+ Venus+) 
zeer hoog verrijkt met onvolwassen hematopoietische voorlopercellen. Belangrijk 
is dat HSC activiteit is uitsluitend geobserveerd in de Gata2 expressie brengende cel 
fractie.
 In Hoofdstuk 4 presenteer ik de genoomwijde bindingsprofiel van tien tran-
scriptiefactoren waarvan is aangetoond dat ze een belangrijke rol spelen bij het reg-
uleren van hematopoiese. Bioinformatische analyses van deze datasets suggereren 
genoomwijde combinatorische interacties tussen deze belangrijke regulatoren van 
hematopoiese en suggereren verder het bestaan van een “heptameer” van tran-
scriptiefactoren geassocieerd met hematopoïetische cellen. Deze gegevens sugger-
eren het bestaan van eerder niet geïdentificeerde transcriptiefactoren interacties. 
Tot slot, functionele experimenten in Gata2+/- Runx1+/- embryo’s tonen aan dat deze 
twee belangrijke hematopoietische regulatoren hebben een samenwerkend effect 
in hun functie, wat suggereert dat de gegevens uit de bioinformatische analyse een 
nuttig hulpmiddel kan zijn bij het begrijpen van transcriptiefactoren samenwerking 
in het reguleren van specifieke processen zoals hematopoiese.
 Kortom, in dit proefschrift beschrijf ik het genereren van een nieuwe Gata2-
Venus reporter muis ES cellijn model dat de identificatie van Gata2 expressie bren-
gende cellen in vivo en hun isolatie mogelijk maakt voor de functionele in vivo en in 
vitro assays. Ik toon aan dat alle HSC activiteit in de muis embryo wordt gevonden 
in de Gata2 expressie brengende celfractie en dat deze celpopulatie is hoog verrijkt 
in hematopoëtische voorlopercellen. Gata2 blijkt te werken in een combinatorische 
wijze samen met andere belangrijke regulatoren van hematopoiese. Het belangri-
jkste is dat ik voor het eerste keer, door time-lapse imaging, laat zien dat Gata2 
expressie op E10 embryonale slagader dynamische veranderingen ondergaat. Deze 
96
studies hebben onze kennis van Gata2 en de regulering en ontwikkeling van hema-
topoietische stamcellen uitgebreid.
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